

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0000536"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0000536" />

    <meta name="citation_title" content="Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau"/>
    <meta itemprop="name" content="Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau"/>

      <meta name="citation_author" content="Simon Melov"/>
            <meta name="citation_author_institution" content="Buck Institute for Age Research, Novato, California, United States of America"/>
      <meta name="citation_author" content="Paul A. Adlard"/>
            <meta name="citation_author_institution" content="Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia"/>
      <meta name="citation_author" content="Karl Morten"/>
            <meta name="citation_author_institution" content="Buck Institute for Age Research, Novato, California, United States of America"/>
      <meta name="citation_author" content="Felicity Johnson"/>
            <meta name="citation_author_institution" content="Buck Institute for Age Research, Novato, California, United States of America"/>
      <meta name="citation_author" content="Tamara R. Golden"/>
            <meta name="citation_author_institution" content="Buck Institute for Age Research, Novato, California, United States of America"/>
      <meta name="citation_author" content="Doug Hinerfeld"/>
            <meta name="citation_author_institution" content="Buck Institute for Age Research, Novato, California, United States of America"/>
      <meta name="citation_author" content="Birgit Schilling"/>
            <meta name="citation_author_institution" content="Buck Institute for Age Research, Novato, California, United States of America"/>
      <meta name="citation_author" content="Christine Mavros"/>
            <meta name="citation_author_institution" content="Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia"/>
      <meta name="citation_author" content="Colin L. Masters"/>
            <meta name="citation_author_institution" content="Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia"/>
      <meta name="citation_author" content="Irene Volitakis"/>
            <meta name="citation_author_institution" content="Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia"/>
      <meta name="citation_author" content="Qiao-Xin Li"/>
            <meta name="citation_author_institution" content="Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia"/>
      <meta name="citation_author" content="Katrina Laughton"/>
            <meta name="citation_author_institution" content="Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia"/>
      <meta name="citation_author" content="Alan Hubbard"/>
            <meta name="citation_author_institution" content="School of Public Health, EHS/Biostatistics, University of California Berkeley, Berkeley, California, United States of America"/>
      <meta name="citation_author" content="Robert A. Cherny"/>
            <meta name="citation_author_institution" content="Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia"/>
      <meta name="citation_author" content="Brad Gibson"/>
            <meta name="citation_author_institution" content="Buck Institute for Age Research, Novato, California, United States of America"/>
      <meta name="citation_author" content="Ashley I. Bush"/>
            <meta name="citation_author_institution" content="Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia"/>
            <meta name="citation_author_institution" content="Department of Psychiatry, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America"/>

    <meta name="citation_date" content="2007/6/20"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0000536.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e536"/>
    <meta name="citation_issue" content="6"/>
    <meta name="citation_volume" content="2"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Heterozygous deficiency of manganese superoxide dismutase results in severe lipid peroxidation and spontaneous apoptosis in murine myocardium in vivo.; citation_author=M Strassburger; citation_author=W Bloch; citation_author=S Sulyok; citation_author=J Schuller; citation_author=AF Keist; citation_journal_title=Free Radical Biology and Medicine; citation_volume=38; citation_number=1; citation_pages=1458-1470; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics.; citation_author=S Melov; citation_author=SR Doctrow; citation_author=JA Schneider; citation_author=J Haberson; citation_author=M Patel; citation_journal_title=Journal of Neuroscience; citation_volume=21; citation_number=2; citation_pages=8348-8353; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase.; citation_author=S Melov; citation_author=JA Schneider; citation_author=BJ Day; citation_author=D Hinerfeld; citation_author=P Coskun; citation_journal_title=Nature Genetics; citation_volume=18; citation_number=3; citation_pages=159-163; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Optic neuropathy induced by reductions in mitochondrial superoxide dismutase.; citation_author=X Qi; citation_author=AS Lewin; citation_author=WW Hauswirth; citation_author=J Guy; citation_journal_title=Investigative Ophthalmology and Visual Science; citation_volume=44; citation_number=4; citation_pages=1088-1096; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase.; citation_author=Y Li; citation_author=TT Huang; citation_author=EJ Carlson; citation_author=S Melov; citation_author=PC Ursell; citation_journal_title=Nature Genetics; citation_volume=11; citation_number=5; citation_pages=376-381; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Genetic modification of prenatal lethality and dilated cardiomyopathy in Mn superoxide dismutase mutant mice.; citation_author=TT Huang; citation_author=EJ Carlson; citation_author=HM Kozy; citation_author=S Mantha; citation_author=SI Goodman; citation_journal_title=Free Radical Biology and Medicine; citation_volume=31; citation_number=6; citation_pages=1101-1110; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant.; citation_author=JS Friedman; citation_author=VI Rebel; citation_author=R Derby; citation_author=K Bell; citation_author=TT Huang; citation_journal_title=Journal of Experimental Medicine; citation_volume=193; citation_number=7; citation_pages=925-934; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness.; citation_author=JS Friedman; citation_author=MF Lopez; citation_author=MD Fleming; citation_author=A Rivera; citation_author=FM Martin; citation_journal_title=Blood; citation_volume=104; citation_number=8; citation_pages=2565-2573; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging.; citation_author=H Van Remmen; citation_author=Y Ikeno; citation_author=M Hamilton; citation_author=M Pahlavani; citation_author=N Wolf; citation_journal_title=Physiol Genomics; citation_volume=16; citation_number=9; citation_pages=29-37; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Mitochondrial oxidative stress causes chromosomal instability of mouse embryonic fibroblasts.; citation_author=E Samper; citation_author=DG Nicholls; citation_author=S Melov; citation_journal_title=Aging Cell; citation_volume=2; citation_number=10; citation_pages=277-285; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Mitochondrial disease in superoxide dismutase 2 mutant mice.; citation_author=S Melov; citation_author=P Coskun; citation_author=M Patel; citation_author=R Tuinstra; citation_author=B Cottrell; citation_journal_title=Proceedings of the National Academy of Sciences of the United States of America; citation_volume=96; citation_number=11; citation_pages=846-851; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice.; citation_author=D Hinerfeld; citation_author=MD Traini; citation_author=RP Weinberger; citation_author=B Cochran; citation_author=SR Doctrow; citation_journal_title=Journal of Neurochemistry; citation_volume=88; citation_number=12; citation_pages=657-667; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties.; citation_author=SS Ali; citation_author=JI Hardt; citation_author=KL Quick; citation_author=JS Kim-Han; citation_author=BF Erlanger; citation_journal_title=Free Radical Biology and Medicine; citation_volume=37; citation_number=13; citation_pages=1191-1202; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Pharmacogenomic profiling of an oxidative stress-mediated spongiform encephalopathy.; citation_author=TR Golden; citation_author=A Hubbard; citation_author=KJ Morten; citation_author=D Hinerfeld; citation_author=S Melov; citation_journal_title=Free Radical Biology and Medicine; citation_volume=39; citation_number=14; citation_pages=152-163; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Neurodegenerative diseases and oxidative stress.; citation_author=KJ Barnham; citation_author=CL Masters; citation_author=AI Bush; citation_journal_title=Nat Rev Drug Discov; citation_volume=3; citation_number=15; citation_pages=205-214; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Tau pathology in Alzheimer disease and other tauopathies.; citation_author=K Iqbal; citation_author=C Alonso Adel; citation_author=S Chen; citation_author=MO Chohan; citation_author=E El-Akkad; citation_journal_title=Biochimica et Biophysica Acta; citation_volume=1739; citation_number=16; citation_pages=198-210; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology.; citation_author=B Schonheit; citation_author=R Zarski; citation_author=TG Ohm; citation_journal_title=Neurobiology of Aging; citation_volume=25; citation_number=17; citation_pages=697-711; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.; citation_author=X Huang; citation_author=CS Atwood; citation_author=MA Hartshorn; citation_author=G Multhaup; citation_author=LE Goldstein; citation_journal_title=Biochemistry; citation_volume=38; citation_number=18; citation_pages=7609-7616; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).; citation_author=C Opazo; citation_author=X Huang; citation_author=RA Cherny; citation_author=RD Moir; citation_author=AE Roher; citation_journal_title=J Biol Chem; citation_volume=277; citation_number=19; citation_pages=40302-40308; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice [see comments].; citation_author=K Hsiao; citation_author=P Chapman; citation_author=S Nilsen; citation_author=C Eckman; citation_author=Y Harigaya; citation_journal_title=Science; citation_volume=274; citation_number=20; citation_pages=99-102; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Intraneuronal Abeta accumulation precedes plaque formation in beta- amyloid precursor protein and presenilin-1 double-transgenic mice.; citation_author=O Wirths; citation_author=G Multhaup; citation_author=C Czech; citation_author=V Blanchard; citation_author=S Moussaoui; citation_journal_title=Neuroscience Letters; citation_volume=306; citation_number=21; citation_pages=116-120; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Mouse models of Alzheimer's disease: a quest for plaques and tangles.; citation_author=JA Richardson; citation_author=DK Burns; citation_journal_title=Ilar J; citation_volume=43; citation_number=22; citation_pages=89-99; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.; citation_author=S Oddo; citation_author=A Caccamo; citation_author=JD Shepherd; citation_author=MP Murphy; citation_author=TE Golde; citation_journal_title=Neuron; citation_volume=39; citation_number=23; citation_pages=409-421; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.; citation_author=S Oddo; citation_author=A Caccamo; citation_author=M Kitazawa; citation_author=BP Tseng; citation_author=FM LaFerla; citation_journal_title=Neurobiology of Aging; citation_volume=24; citation_number=24; citation_pages=1063-1070; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Tau suppression in a neurodegenerative mouse model improves memory function.; citation_author=K Santacruz; citation_author=J Lewis; citation_author=T Spires; citation_author=J Paulson; citation_author=L Kotilinek; citation_journal_title=Science; citation_volume=309; citation_number=25; citation_pages=476-481; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice.; citation_author=L Esposito; citation_author=J Raber; citation_author=L Kekonius; citation_author=F Yan; citation_author=GQ Yu; citation_journal_title=J Neurosci; citation_volume=26; citation_number=26; citation_pages=5167-5179; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice.; citation_author=F Li; citation_author=NY Calingasan; citation_author=F Yu; citation_author=WM Mauck; citation_author=M Toidze; citation_journal_title=Journal of Neurochemistry; citation_volume=89; citation_number=27; citation_pages=1308-1312; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Single and multiple transgenic mice as models for Alzheimer's disease.; citation_author=F van Leuven; citation_journal_title=Progress in Neurobiology; citation_volume=61; citation_number=28; citation_pages=305-312; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.; citation_author=L Holcomb; citation_author=MN Gordon; citation_author=E McGowan; citation_author=X Yu; citation_author=S Benkovic; citation_journal_title=Nature Medicine; citation_volume=4; citation_number=29; citation_pages=97-100; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice.; citation_author=MJ Callahan; citation_author=WJ Lipinski; citation_author=F Bian; citation_author=RA Durham; citation_author=A Pack; citation_journal_title=American Journal of Pathology; citation_volume=158; citation_number=30; citation_pages=1173-1177; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Gallyas-Schiff stain for senile plaques.; citation_author=K Kobayashi; citation_author=K Miyazu; citation_author=Y Fukutani; citation_author=I Nakamura; citation_author=N Yamaguchi; citation_journal_title=Biotechnic and Histochemistry; citation_volume=67; citation_number=31; citation_pages=256-260; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.; citation_author=JC Augustinack; citation_author=A Schneider; citation_author=EM Mandelkow; citation_author=BT Hyman; citation_journal_title=Acta Neuropathologica; citation_volume=103; citation_number=32; citation_pages=26-35; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity.; citation_author=H White; citation_journal_title=Econometrica; citation_volume=48; citation_number=33; citation_pages=817-830; citation_date=1980; " />
      <meta name="citation_reference" content="citation_title=Probability-based protein identification by searching sequence databases using mass spectrometry data.; citation_author=DN Perkins; citation_author=DJ Pappin; citation_author=DM Creasy; citation_author=JS Cottrell; citation_journal_title=Electrophoresis; citation_volume=20; citation_number=34; citation_pages=3551-3567; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology.; citation_author=CJ Maynard; citation_author=R Cappai; citation_author=I Volitakis; citation_author=RA Cherny; citation_author=CL Masters; citation_journal_title=J Inorg Biochem; citation_volume=100; citation_number=35; citation_pages=952-962; citation_date=2006; " />
      <meta name="citation_reference" content="citation_author=JD Bancroft; citation_author=A Stevens; citation_number=36; citation_date=1996; citation_publisher=Churchill Livingtone; " />
      <meta name="citation_reference" content="citation_title=Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.; citation_author=I Dewachter; citation_author=J van Dorpe; citation_author=K Spittaels; citation_author=I Tesseur; citation_author=C Van Den Haute; citation_journal_title=Experimental Gerontology; citation_volume=35; citation_number=37; citation_pages=831-841; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts.; citation_author=SA Bellingham; citation_author=GD Ciccotosto; citation_author=BE Needham; citation_author=LR Fodero; citation_author=AR White; citation_journal_title=J Neurochem; citation_volume=91; citation_number=38; citation_pages=423-428; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron.; citation_author=CJ Maynard; citation_author=R Cappai; citation_author=I Volitakis; citation_author=RA Cherny; citation_author=AR White; citation_journal_title=J Biol Chem; citation_volume=277; citation_number=39; citation_pages=44670-44676; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice.; citation_author=TA Bayer; citation_author=S Schafer; citation_author=A Simons; citation_author=A Kemmling; citation_author=T Kamer; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=100; citation_number=40; citation_pages=14187-14192; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=In vivo reduction of amyloid-beta by a mutant copper transporter.; citation_author=AL Phinney; citation_author=B Drisaldi; citation_author=SD Schmidt; citation_author=S Lugowski; citation_author=V Coronado; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=100; citation_number=41; citation_pages=14193-14198; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Rapid induction of Alzheimer A beta amyloid formation by zinc.; citation_author=AI Bush; citation_author=WH Pettingell; citation_author=G Multhaup; citation_author=M d Paradis; citation_author=JP Vonsattel; citation_journal_title=Science; citation_volume=265; citation_number=42; citation_pages=1464-1467; citation_date=1994; " />
      <meta name="citation_reference" content="citation_title=The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease.; citation_author=MC Galas; citation_author=P Dourlen; citation_author=S Begard; citation_author=K Ando; citation_author=D Blum; citation_journal_title=J Biol Chem; citation_volume=281; citation_number=43; citation_pages=19296-19304; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia?; citation_author=JP Blass; citation_journal_title=Journal of Neuroscience Research; citation_volume=66; citation_number=44; citation_pages=851-856; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress.; citation_author=MA Smith; citation_author=K Hirai; citation_author=K Hsiao; citation_author=MA Pappolla; citation_author=PL Harris; citation_journal_title=Journal of Neurochemistry; citation_volume=70; citation_number=45; citation_pages=2212-2215; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Mitochondrial Abnormalities: A Primary Basis for Oxidative Damage in Alzheimer's Disease.; citation_author=MA Smith; citation_author=K Hirai; citation_author=A Nunomura; citation_author=G Perry; citation_journal_title=Drug Develop Res; citation_volume=46; citation_number=46; citation_pages=26-33; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.; citation_author=JW Lustbader; citation_author=M Cirilli; citation_author=C Lin; citation_author=HW Xu; citation_author=K Takuma; citation_journal_title=Science; citation_volume=304; citation_number=47; citation_pages=448-452; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction.; citation_author=K Takuma; citation_author=J Yao; citation_author=J Huang; citation_author=H Xu; citation_author=X Chen; citation_journal_title=Faseb J; citation_volume=19; citation_number=48; citation_pages=597-598; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Therapeutic treatments for Alzheimer's disease based on metal bioavailability.; citation_author=PJ Crouch; citation_author=KJ Barnham; citation_author=AI Bush; citation_author=AR White; citation_journal_title=Drug News Perspect; citation_volume=19; citation_number=49; citation_pages=469-474; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Differential neuronal expression of manganese superoxide dismutase in Alzheimer's disease.; citation_author=DL Marcus; citation_author=JA Strafaci; citation_author=ML Freedman; citation_journal_title=Med Sci Monit; citation_volume=12; citation_number=50; citation_pages=BR8-14; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Characterization of the antioxidant status of the heterozygous manganese superoxide dismutase knockout mouse.; citation_author=H Van Remmen; citation_author=C Salvador; citation_author=H Yang; citation_author=TT Huang; citation_author=CJ Epstein; citation_journal_title=Archives of Biochemistry and Biophysics; citation_volume=363; citation_number=51; citation_pages=91-97; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis.; citation_author=H Van Remmen; citation_author=MD Williams; citation_author=Z Guo; citation_author=L Estlack; citation_author=H Yang; citation_journal_title=Am J Physiol Heart Circ Physiol; citation_volume=281; citation_number=52; citation_pages=H1422-1432; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Oxidative stress mediates tau-induced neurodegeneration in Drosophila.; citation_author=D Dias-Santagata; citation_author=TA Fulga; citation_author=A Duttaroy; citation_author=MB Feany; citation_journal_title=J Clin Invest; citation_volume=117; citation_number=53; citation_pages=236-245; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau.; citation_author=B Li; citation_author=MO Chohan; citation_author=I Grundke-Iqbal; citation_author=K Iqbal; citation_journal_title=Acta Neuropathol (Berl); citation_volume=113; citation_number=54; citation_pages=501-511; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.; citation_author=RA Cherny; citation_author=CS Atwood; citation_author=ME Xilinas; citation_author=DN Gray; citation_author=WD Jones; citation_journal_title=Neuron; citation_volume=30; citation_number=55; citation_pages=665-676; citation_date=2001; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000536" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau"/>
    <meta name="twitter:description" content="
Age-related neurodegenerative disease has been mechanistically linked with mitochondrial dysfunction via damage from reactive oxygen species produced within the cell. We determined whether increased mitochondrial oxidative stress could modulate or regulate two of the key neurochemical hallmarks of Alzheimer's disease (AD): tau phosphorylation, and &szlig;-amyloid deposition. Mice lacking superoxide dismutase 2 (SOD2) die within the first week of life, and develop a complex heterogeneous phenotype arising from mitochondrial dysfunction and oxidative stress. Treatment of these mice with catalytic antioxidants increases their lifespan and rescues the peripheral phenotypes, while uncovering central nervous system pathology. We examined sod2 null mice differentially treated with high and low doses of a catalytic antioxidant and observed striking elevations in the levels of tau phosphorylation (at Ser-396 and other phospho-epitopes of tau) in the low-dose antioxidant treated mice at AD-associated residues. This hyperphosphorylation of tau was prevented with an increased dose of the antioxidant, previously reported to be sufficient to prevent neuropathology. We then genetically combined a well-characterized mouse model of AD (Tg2576) with heterozygous sod2 knockout mice to study the interactions between mitochondrial oxidative stress and cerebral A&szlig; load. We found that mitochondrial SOD2 deficiency exacerbates amyloid burden and significantly reduces metal levels in the brain, while increasing levels of Ser-396 phosphorylated tau. These findings mechanistically link mitochondrial oxidative stress with the pathological features of AD.
"/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0000536.g008"/>

  <meta property="og:title" content="Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000536" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=5651'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=7220'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=9371&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0000536">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000536" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000536&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Simon Melov
              <span class="corresponding">mail</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:smelov@buckinstitute.org">smelov@buckinstitute.org</a> (SM); <a href="mailto:bush@helix.mgh.harvard.edu">bush@helix.mgh.harvard.edu</a> (AIB)</p>

                <p>Affiliation:
                  Buck Institute for Age Research, Novato, California, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Paul A. Adlard, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Karl Morten, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Buck Institute for Age Research, Novato, California, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Felicity Johnson, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Buck Institute for Age Research, Novato, California, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Tamara R. Golden, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Buck Institute for Age Research, Novato, California, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Doug Hinerfeld, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Buck Institute for Age Research, Novato, California, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Birgit Schilling, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Buck Institute for Age Research, Novato, California, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Christine Mavros, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Colin L. Masters, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Irene Volitakis, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Qiao-Xin Li, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Katrina Laughton, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Alan Hubbard, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  School of Public Health, EHS/Biostatistics, University of California Berkeley, Berkeley, California, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Robert A. Cherny, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Brad Gibson, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Buck Institute for Age Research, Novato, California, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Ashley I. Bush
              <span class="corresponding">mail</span>
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:smelov@buckinstitute.org">smelov@buckinstitute.org</a> (SM); <a href="mailto:bush@helix.mgh.harvard.edu">bush@helix.mgh.harvard.edu</a> (AIB)</p>

                <p>Affiliations:
                  Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia, 
                  Department of Psychiatry, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: June 20, 2007</li>
    <li>DOI: 10.1371/journal.pone.0000536</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0000536" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0000536" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000536" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0000536" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0000536-g001" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000536-t001" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000536-g002" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000536-g003" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g003" title="Figure 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000536-g004" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g004" title="Figure 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000536-g005" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g005" title="Figure 5">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g005&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000536-g006" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g006" title="Figure 6">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g006&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000536-g007" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g007" title="Figure 7">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g007&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000536-g008" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g008" title="Figure 8">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g008&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000536">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0000536" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2><a id="article1.front1.article-meta1.abstract1.p1" name="article1.front1.article-meta1.abstract1.p1"></a><p>Age-related neurodegenerative disease has been mechanistically linked with mitochondrial dysfunction via damage from reactive oxygen species produced within the cell. We determined whether increased mitochondrial oxidative stress could modulate or regulate two of the key neurochemical hallmarks of Alzheimer's disease (AD): tau phosphorylation, and ß-amyloid deposition. Mice lacking superoxide dismutase 2 (SOD2) die within the first week of life, and develop a complex heterogeneous phenotype arising from mitochondrial dysfunction and oxidative stress. Treatment of these mice with catalytic antioxidants increases their lifespan and rescues the peripheral phenotypes, while uncovering central nervous system pathology. We examined <em>sod2</em> null mice differentially treated with high and low doses of a catalytic antioxidant and observed striking elevations in the levels of tau phosphorylation (at Ser-396 and other phospho-epitopes of tau) in the low-dose antioxidant treated mice at AD-associated residues. This hyperphosphorylation of tau was prevented with an increased dose of the antioxidant, previously reported to be sufficient to prevent neuropathology. We then genetically combined a well-characterized mouse model of AD (Tg2576) with heterozygous <em>sod2</em> knockout mice to study the interactions between mitochondrial oxidative stress and cerebral Aß load. We found that mitochondrial SOD2 deficiency exacerbates amyloid burden and significantly reduces metal levels in the brain, while increasing levels of Ser-396 phosphorylated tau. These findings mechanistically link mitochondrial oxidative stress with the pathological features of AD.</p>
</div>


<div class="articleinfo"><p><strong>Citation: </strong>Melov S, Adlard PA, Morten K, Johnson F, Golden TR, et al.  (2007) Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau. PLoS ONE 2(6):
          e536.
            doi:10.1371/journal.pone.0000536</p><p><strong>Academic Editor: </strong>Joseph El Khoury, Massachusetts General Hospital &amp; Harvard Medical School, United States of America</p><p><strong>Received:</strong> April 3, 2007; <strong>Accepted:</strong> May 16, 2007; <strong>Published:</strong> June 20, 2007</p><p><strong>Copyright:</strong> © 2007 Melov et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>This work was supported by National Institutes of Health grants AG18679 and PO1 AG25901 (S.M), AG12686 (A.I.B.), and a grant from the American Health Assistance Foundation (A.I.B.). It was also supported by an award from the Institute for the Study of Aging and an Ellison Medical Foundation award (S.M); the Australian Research Council Federation Fellowship (A.I.B.); the National Health and Medical Research Council Howard Florey Centenary Research Fellowship (P.A). We would like to thank Nicole Nagulko and Lawreen Asuncion for excellent animal work, and Sue Doctrow for helpful comments.</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Mitochondria are a main source of potentially pathogenic reactive oxygen species (ROS) such as superoxide, particularly in highly metabolically active organs such as the brain and heart <a href="#pone.0000536-Strassburger1">[1]</a>–<a href="#pone.0000536-Melov2">[3]</a>. The chief defense against superoxide produced during the course of respiration is mitochondrial superoxide dismutase (SOD2). Mice have been genetically modified to lack <em>sod2</em> in specific tissues <a href="#pone.0000536-Strassburger1">[1]</a>, <a href="#pone.0000536-Qi1">[4]</a>, or systemically in multiple genetic backgrounds <a href="#pone.0000536-Li1">[5]</a>, <a href="#pone.0000536-Huang1">[6]</a>. The resulting phenotypes include neonatal or embryonic lethality <a href="#pone.0000536-Li1">[5]</a>, <a href="#pone.0000536-Huang1">[6]</a>, cardiomyopathy <a href="#pone.0000536-Li1">[5]</a>, <a href="#pone.0000536-Huang1">[6]</a>, hemolytic anemia <a href="#pone.0000536-Friedman1">[7]</a>, <a href="#pone.0000536-Friedman2">[8]</a>, seizures <a href="#pone.0000536-Huang1">[6]</a>, increased incidence of cancer <a href="#pone.0000536-VanRemmen1">[9]</a>, genomic instability <a href="#pone.0000536-Samper1">[10]</a>, mitochondrial biochemical defects <a href="#pone.0000536-Melov3">[11]</a>, <a href="#pone.0000536-Hinerfeld1">[12]</a>, spongiform encephalopathy <a href="#pone.0000536-Melov2">[3]</a>, optic neuropathy <a href="#pone.0000536-Qi1">[4]</a>, movement disorders <a href="#pone.0000536-Melov2">[3]</a>, <a href="#pone.0000536-Huang1">[6]</a> and neurodegeneration <a href="#pone.0000536-Hinerfeld1">[12]</a>. These phenotypes arise due to endogenous oxidative stress and several antioxidant interventions have been applied to the <em>sod2</em> nullizygous mouse model <a href="#pone.0000536-Melov1">[2]</a>, <a href="#pone.0000536-Melov2">[3]</a>, <a href="#pone.0000536-Ali1">[13]</a>. Some of these interventions have striking efficacy in preventing cardiomyopathy, extending lifespan, preventing spongiform encephalopathy <a href="#pone.0000536-Melov1">[2]</a>, <a href="#pone.0000536-Melov2">[3]</a>, reducing anemia <a href="#pone.0000536-Friedman1">[7]</a>, increasing mitochondrial enzyme activity, reducing neurodegeneration and attenuating gene expression characteristic of mitochondrially mediated spongiform encephalopathy <a href="#pone.0000536-Hinerfeld1">[12]</a>, <a href="#pone.0000536-Golden1">[14]</a>.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is associated with oxidative stress <a href="#pone.0000536-Barnham1">[15]</a> and the accumulation of two characteristic pathologies, neurofibrillary tangles, composed primarily of hyperphosphorylated aggregates of tau <a href="#pone.0000536-Iqbal1">[16]</a>, and amyloid plaques, largely composed of aggregated Aß <a href="#pone.0000536-Schonheit1">[17]</a>. Aß binds copper and zinc selectively in AD tissue, and Aß:Cu complexes are a catalytic source of H<sub>2</sub>O<sub>2</sub> <a href="#pone.0000536-Huang2">[18]</a>, <a href="#pone.0000536-Opazo1">[19]</a>. The molecular mechanism that results in an aggregation of Aß with increasing age in the brain is still uncertain, but abnormal interactions with biometals (principally copper and zinc) may play a prominent role <a href="#pone.0000536-Barnham1">[15]</a>. To aid in the development of therapeutic strategies for AD, a number of animal models have been developed which recapitulate the plaque pathology <a href="#pone.0000536-Hsiao1">[20]</a>–<a href="#pone.0000536-Richardson1">[22]</a>. However, only recently have transgenic mice been developed which model the two key neuropathologies associated with AD <a href="#pone.0000536-Oddo1">[23]</a>. These mice progressively develop both amyloid and tau pathology, which are both associated with synaptic dysfunction. Of note in this genetic model, Aß deposition preceded the development of phosphorylated tau, and the distribution of phospho-tau closely recapitulated the distribution of tangles that characterize the human disease <a href="#pone.0000536-Oddo2">[24]</a>. More recently, transgenic mice were developed which overexpressed mutant tau by 7–13 fold, resulting in mice that develop a tauopathy associated with neurodegeneration and impaired cognition <a href="#pone.0000536-Santacruz1">[25]</a>. Mice that model mitochondrial dysfunction and Alzheimers disease have only recently been developed <a href="#pone.0000536-Esposito1">[26]</a>, <a href="#pone.0000536-Li2">[27]</a>. Mice overexpressing mutant APP were crossed with mice heterozygous for <em>sod2</em>, resulting in strains of mice with acceleration of amyloid accumulation, in addition to increasing behavioral defects in one strain <a href="#pone.0000536-Esposito1">[26]</a>.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>A key question that remains unresolved in all currently available animal models of AD, is how well do they model AD where there are no mutations in either APP or tau? The majority of current animal models of AD are based on the overexpression of mutant forms of genes associated with AD linked to aggressive familial mutations <a href="#pone.0000536-Hsiao1">[20]</a>, <a href="#pone.0000536-Oddo1">[23]</a>, <a href="#pone.0000536-Santacruz1">[25]</a>, <a href="#pone.0000536-vanLeuven1">[28]</a>, <a href="#pone.0000536-Holcomb1">[29]</a>. Therefore, a significant need exists for the development of animal models of the neuropathology of AD, which are not based upon overexpression of mutant human proteins. Here we describe a novel model for AD neuropathology, showing that mice that lack <em>sod2</em> express AD-like hyperphosphorylation of tau, the protein component of neurofibrillary tangles. We show that this hyperphosphorylation of tau is attributable to mitochondrial oxidative stress. We also show that mice that are both transgenic for APP, and hemizygous for <em>sod2</em>, incur a higher level of tau phosphorylation, higher amyloid burden and decreased copper, zinc and manganese levels, consistent with a synergistic interaction between APP and mitochondrial oxidative stress in contributing to AD-like neocortical pathology.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Methods"></a><h3>Methods</h3>
<h4>Animal husbandry</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p><em>Sod2</em> nullizgyous mice of both sexes were genotyped between 2 and 3 days of age, and injected intraperitoneally with EUK189 at either 1 mg/kg (low dose) or 30 mg/kg (high dose) daily from 3 days of age until sacrifice, as previously described <a href="#pone.0000536-Melov1">[2]</a>, <a href="#pone.0000536-Melov2">[3]</a>. EUK189 was purchased from Dalton Chemical Laboratories, Inc (Toronto, Canada). Wild type animals as well as <em>sod2</em> nullizygous mice were treated to control for compound specific effects. Mice were killed at 18–21 days of age and cortex harvested immediately for use in histological or biochemical studies.</p>
<a id="article1.body1.sec2.sec1.p2" name="article1.body1.sec2.sec1.p2"></a><p>Tg2576:<em>sod2</em> hybrid mice were created by crossing C57BL/6 <em>sod2</em> null mice (a kind gift of C.J. Epstein) to SJL mice to create F1 C57BL/6:SJL <em>sod2</em> heterozygotes. These mice were then crossed to APP mice (Tg2576 <a href="#pone.0000536-Hsiao1">[20]</a>, on an identical genetic background), to generate Tg2576:<em>sod2</em> mice, which were maintained and bred as previously reported <a href="#pone.0000536-Hsiao1">[20]</a>. Tg2576:<em>sod2</em> mice, Tg2576 mice, and C57BL/6:SJL F1 hybrid <em>sod2</em> heterozygotes were maintained under barrier conditions until 497–527 days of age, when they were killed and neocortices were either harvested and frozen for biochemical analysis, or fixed in neutral buffered formalin for histological processing using standard protocols. We chose female Tg2576 mice to study because they have more robust plaque changes <a href="#pone.0000536-Callahan1">[30]</a>. All animal procedures were carried out under approved IACUC animal protocols at the Buck Institute, which is AAALAC accredited.</p>


<h4>Immunohistochemistry</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>Parrafin embedded brain tissue was cut at a thickness of 8 µm, and tissue sections were de-paraffinised with xylene and re-hydrated through a stepwise series of ethanol solutions (100%, 95%, 70%). Non-specific background was reduced by a 5 minute pre-incubation in 0.5X PBS, in 10% methanol plus 3% hydrogen peroxide for 20 to 30 minutes. Antigen retrieval was routinely used with a commercially available kit (Antigen Unmasking Solution, Vector Lab., Burlingame CA). All slides were blocked (0.01X PBS, 5% v/v normal donkey serum, 0.1% Triton X-100) for 2 hours at room temperature, after which the primary antibody (rabbit anti-phospho-Ser 396 tau antibody, BioSource, Camarillo, CA) was added and left over 2 nights at 4°C. To ensure specificity of signal, a specific phospho-blocking peptide for phospho Ser-396 was used on adjacent serial sections (BioSource), which completely blocked the signal from the primary antibody. The secondary antibody (1:500, Biotin-SP-conjugated donkey anti-rabbit IgG, Jackson ImmunoResearch Lab, West Grove, PA) was incubated for one hour at room temperature and the resulting signal was visualized using the Vectastain ABC kit and VectaDAB kit (Vector Laboratories, Burlingame, CA) according to the manufacturer's instructions. All slides were counterstained in Mayer's Haematoxylin for 30 seconds, and then dehydrated before the application of cover-slips, and subsequent photography using a digital camera (AxioVision v3.1, Carl Zeiss Vision). Silver staining for detection of possible neurofibrillary tangles, was performed as previously described <a href="#pone.0000536-Kobayashi1">[31]</a>, with the following modifications: immersion in the alkaline solution was 10 seconds, and the physical developer components for 25°C (10 mL solution A+5 mL solution B+5 mL solution C) were used immediately after mixing. Sections were developed in this solution until they had turned pale to mid-grey (approximately 20 to 30 minutes).</p>
<a id="article1.body1.sec2.sec2.p2" name="article1.body1.sec2.sec2.p2"></a><p>For evaluating amyloid load, we cut 7 µm coronal sections from formalin-fixed brain tissue. The sections were treated with 80% formic acid for antigen retrieval before probing with monoclonal antibody 1E8 that recognizes an epitope between residues 18 and 22 of Aβ (Glaxo SmithKline, UK). All sections were imaged on a Northern Light Illuminator (Imaging Research Inc, Ontario, Canada) using a Spot RT-KE 2MP digital camera (Diagnostic Instruments, MI, USA) equipped with a Nikkon 55 mm lens and 56 mm extension tube set. Each image was analyzed using ImagePro Plus 5.1 (Media Cybernetics, MD, USA). For each image an “area of interest” (AOI) line was drawn around the margins of the brain occupied by the hippocampus and cortex. The number of ß-amyloid-positive structures present in each section were then quantitated using color selection to separate the plaques from background labeling. A filter was also utilized to only include structures that were greater than 10 pixels in size. This data was expressed as the total number of ß-amyloid-positive pixels in each section and was exported to Microsoft Excel for analysis. Based upon the known size of each AOI, all values were normalized to allow comparisons between sections of different surface area and were expressed as pixels/mm<sup>2</sup>. Average Aß load was assessed in the cortex and underlying grey matter taken from two sections from each animal and all counts represent Aß found only in plaques. In all cases, the investigator undertaking the analyses was blinded to animal genotype.</p>


<h4>Western blotting and quantitation of phospho tau</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>Protein was extracted from mouse cortex by homogenizing in tissue extraction buffer (50 mM Tris HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% Triton, 0.1% SDS) containing mini complement protease inhibitors (Roche) at 4°C. Cellular debris was removed by centrifuging at 10,000 rpm in a bench top centrifuge for 5 minutes. Supernatant fractions were removed, and protein concentrations determined using a BCA protein assay kit (Pierce Biotechnology, Rockford, IL). Each sample was denatured in standard SDS/Page loading buffer and 2.5 µg of protein run on a NuPage 4–12% Bis Tris gels in MES buffer (Invitrogen, Carlsbad, CA). Proteins were transferred onto a Immuno-Blot PVDF membranes (Bio-Rad, Hercules, CA), according to the manufacturer's instructions. Blocking was carried in a standard 5% fat free milk solution in 1xTBS (0.05% Tween) for 1 hour at room temperature. Five anti-phospho-tau antibodies were employed which were directed against specific residues that had been previously identified as sites of hyper phosphorylation of tau in AD <a href="#pone.0000536-Augustinack1">[32]</a>; Thr-205, Ser-396, Ser-404, Ser-214, Thr-231 (<a href="#pone-0000536-g001">Figure 1</a>). Anti-phospho tau primary antibodies (Biosource, anti phospho-Thr 205, anti phospho-Ser 396, anti phospho-Ser 404, and anti phospho-Thr 214, all rabbit) (Chemicon, Temecula, CA) were typically used at a concentration of between 1:1000 to 1:10000, diluted in blocking buffer. The secondary antibody was an HRP-conjugated goat anti-rabbit (Pierce). Chemiluminescent detection was conducted with the ECL Plus western blotting detection system (Amersham Biosciences, Piscataway, NJ) and X-ray film according to manufacturer's instructions.</p>
<div class="figure" id="pone-0000536-g001"><div class="img"><a name="pone-0000536-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Mitochondrial oxidative stress causes hyperphosphorylation of tau.</span></strong></p><a id="article1.body1.sec2.sec3.fig1.caption1.p1" name="article1.body1.sec2.sec3.fig1.caption1.p1"></a><p>Western blots of cortical extracts from <em>sod2</em> null mice treated with 1 mg/kg (n = 8) of the catalytic antioxidant EUK189 or 30 mg/kg (n = 7) of EUK189 (white bars), or wild-type mice (n = 6, 1 mg/kg; n = 7, 30 mg/kg) treated comparably (black bars), were probed with the following antiphospho-tau antibodies; Thr 205, Ser 396, Ser 404, Ser 214, and Thr-231. Quantitation of chemiluminesence was carried out in the linear range of detection for each of these antibodies, using a regression model to adjust for the total amount of tau (results). P values for comparisons between each of the residues of phospho-tau were derived from the regression model, after correcting for the total amount of tau per group.</p>
<span>doi:10.1371/journal.pone.0000536.g001</span></div><a id="article1.body1.sec2.sec3.p2" name="article1.body1.sec2.sec3.p2"></a><p>A number of preliminary blots were run for each antibody to determine the optimal conditions for quantification of phosphorylated tau. In these preliminary studies, the amount of protein was varied per gel, or the concentration of primary antibody varied in order to estimate the linear range of quantifiable phospho-tau.</p>
<a id="article1.body1.sec2.sec3.p3" name="article1.body1.sec2.sec3.p3"></a><p>Because the amount of tau protein in the sample could potentially contribute to the amount of phosphorylation at specific residues, we normalized by the total amount of tau in each sample. Instead of using a normalized outcome (such as the ratio of residue/tau), we adjust for the amount of tau using a simple linear modeling approach. Specifically, for each residue we estimate the model:<a name="" id=""></a><span class="equation"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.e001&amp;representation=PNG" class="inline-graphic"></span><br>where <em>I(Geno = −/−)</em> is the indicator function ( = 1 if genotype is −/−, 0 otherwise, Tx is treatment). This model permits the testing and estimation of dose effects within genotype and similarly, genotypes within dose groups. The inference was derived using robust standard errors <a href="#pone.0000536-White1">[33]</a>. Note, in none of the models was the amount of total tau significantly associated with a specific outcome (i.e., the p-value of the test of <em>β<sub>4</sub> = 0</em> was &gt;0.05 for all residues). Comparison between specific groups using the above regression modeling after adjusting for total tau and their associated <em>p</em>-values are listed in <a href="#pone-0000536-g001">Figure 1</a>.</p>


<h4>Immunoprecipitation of phosphorylated tau</h4>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1"></a><p>Immunoprecipitation was carried out using the Seize® Primary Immunoprecipitation Kit from Pierce, according to the manufacturer's instructions. 100 µg of Tau-5 anti-tau antibody (BioSource) was coupled to the 200 µl of AminoLink® Plus Coupling Gel Protein as per the manufacturer's instructions. Brain extracts (1.2 mg per mouse, for a total of 6 mg in 750 µl) were pooled from five 18-day-old <em>sod2</em> null mice that had been treated with a low dose of Euk189, or brain extracts (50 µl each) from nine female Tg2576:<em>sod2</em>+/− mice were pooled for a total of 1.8 mg in 450 µl. The pooled extracts were diluted to 5 ml with Binding Buffer, the 200 µl of antibody-coupled resin added, and the mixture rotated overnight at 4°C. Subsequent washes and elution were carried out as per the manufacturer's instructions. All bound tau protein was found to be eluted from the resin in the first 200 µl elution fraction.</p>


<h4>Proteolytic digestion of immunoprecipitated tau</h4>
<a id="article1.body1.sec2.sec5.p1" name="article1.body1.sec2.sec5.p1"></a><p>Phosphorylated tau protein was either immunoprecipitated from single mutant (<em>sod2</em>−/−) mouse brain tissue as described above and was directly processed following a manual in-solution digestion protocol. Approximately 0.3–0.4 µg of immunoprecipitated tau in elution buffer (100 mM glycine) was brought to pH 8.0 by adding 50 mM NH<sub>4</sub>HCO<sub>3</sub> buffer (final total volume 60 µl). Subsequently, acetonitrile (ACN) was added (40% final concentration) to denature the protein. The protein was incubated at 60°C for 30 min with a 500-fold molar excess of reducing reagent DTT over the number of cysteine residues in tau, followed by an incubation at 37°C for 45 min after adding a 1100-fold molar exess of alkylating reagent iodoacetamide (DTT and iodoacetamide were both purchased from Sigma, St. Louis, MO). After dilution of the reaction mixture to 10% ACN, the sample was incubated with 40 ng sequencing grade trypsin (Promega, Madison, WI) at 37°C for 8 hours. The resulting tryptic peptides were acidified with formic acid, and then subjected to mass spectrometric analysis.</p>


<h4>Mass Spectrometric Analysis (ESI-MS/MS)</h4>
<a id="article1.body1.sec2.sec6.p1" name="article1.body1.sec2.sec6.p1"></a><p>The proteolytic peptide mixtures were analyzed by reverse-phase nano-HPLC-MS/MS. Briefly, peptides were separated on an Ultimate nanocapillary HPLC system equipped with a PepMap™ C18 nano-column (75 µm I.D. ×15 cm) (Dionex, Sunnyvale, CA) and CapTrap Micro guard column (0.5 µl bed volume, Michrom, Auburn, CA). Peptide mixtures were loaded onto the guard column and washed with the loading solvent (H<sub>2</sub>O/0.05% formic acid, flow rate: 20 µl/min) for 5 min, then transferred onto the analytical C18-nanocapillary HPLC column and eluted at a flow rate of 300 nl/min using the following gradient: 2% B (from 0–5 min), and 2–70% B (from 5–55 min). Solvent A consisted of 0.05% formic acid in 98% H<sub>2</sub>O/2% ACN and solvent B consisted of 0.05% formic acid in 98% ACN/2% H<sub>2</sub>O. The column eluant was directly coupled to a ‘QSTAR Pulsar i’ quadrupole orthogonal TOF mass spectrometer (MDS Sciex, Concorde, Canada) equipped with a Protana/ProXeon nanospray ion source (ProXeon Biosystems, Odense, Denmark). The nanospray needle voltage was typically 2300 V in the HPLC-MS mode. Mass spectra (ESI-MS) and tandem mass spectra (ESI-MS/MS) were recorded in positive-ion mode with a resolution of 12,000–15,000 FWHM. For collision induced dissociation tandem mass spectrometry, the mass window for precursor ion selection of the quadrupole mass analyzer was set to ±1 <em>m/z</em>. The precursor ions were fragmented in a collision cell using nitrogen as the collision gas. Spectra were calibrated in static nanospray mode using MS/MS fragment-ions of a renin peptide standard (His immonium-ion with <em>m/z</em> at 110.0713, and b<sub>8</sub>-ion with <em>m/z</em> at 1028.5312) providing a mass accuracy of ≤50 ppm. Samples were run at least twice by HPLC-MS/MS. Mass lists were generated of potential phospho-peptides that were observed as ESI-MS fingerprints but were not selected by ESI-MS/MS in the first HPLC run. These mass lists were entered as inclusion lists to the Information Dependent Acquisition of the QSTAR instrument (to be selected for MS/MS) in subsequent runs.</p>


<h4>Database searches for protein identification and additional bioinformatics programs</h4>
<h5>ESI-MS/MS data:.</h5><a id="article1.body1.sec2.sec7.sec1.p1" name="article1.body1.sec2.sec7.sec1.p1"></a><p>ESI-MS/MS data were submitted to our in-house search engine Mascot analyzing peptide sequence information from tandem mass spectra. The search engine Mascot uses a probability based ‘Mowse Score’ to evaluate data obtained from tandem mass spectra, e.g. for a score&gt;37, protein matches are considered significant <a href="#pone.0000536-Perkins1">[34]</a>. All acquired MS/MS spectra of phosphorylated peptides were interpreted and inspected “manually” and compared to the MS/MS spectra of their corresponding non-phosphorylated peptides.</p>

<h5>ESI-MS data:.</h5><a id="article1.body1.sec2.sec7.sec2.p1" name="article1.body1.sec2.sec7.sec2.p1"></a><p>In order to obtain reliable peak lists from ESI-MS data that were generated during an LC-MS run, the programs Mascot Distiller (version 1.1.1) and Mascot Distiller MDRO Software Developers Kit (version 1.1.1) were purchased (Matrix Sciences, London, United Kingdom). An in-house developed java program named “MS-Assign” was used to interface with the Mascot Distiller software that was used for peak picking and to extract and compile ESI-MS peak lists from the LC-MS runs. Subsequently, ESI-PMF peak lists were submitted to our Mascot search engine or Protein Prospector.</p>



<h4>Evaluation of Aß load</h4>
<a id="article1.body1.sec2.sec8.p1" name="article1.body1.sec2.sec8.p1"></a><p>We estimated Aß load using both immunohistochemistry (described above) and the DELFIA® Double Capture ELISA (Ritchie et al., 2003). Briefly, brain tissues (~0.2 g) were homogenized in PBS at a ratio of 1:10 (w/vol), and centrifuged at 100,000 g for 1 hr. The pellet was resuspended in the original volume and further solubilized with guanidine HCl to a final concentration of 5 M followed by centrifugation at 16,000 g for 20 minutes. To measure Aß40 or Aß42, the supernatants were diluted 1:10 with blocking buffer (0.25% casein or Superblock (Pierce) in phosphate-buffered saline with 0.025% Tween-20) before adding to the plate. For the detection of Aß40 or Aß42 in the 100,000 g soluble fraction, 50 µl of the soluble fractions were applied to the ELISA plates. Plates were coated with either G210 (for Aβ40) or G211 (for Aβ42) antibodies, which are specific for the C-terminus of Aβ, then blocked with 0.5% (w/v) casein/PBS or Superblock/PBS buffer (pH 7.4). After washing the plates, WO2-Biotin was added to the wells. The epitope for WO2 is within residues 5–8. Aβ40 and Aβ42 peptide standards and samples were assayed in triplicate, and incubated overnight at 4°C. The plates were washed, europium labelled streptavidin added, and then developed with enhancement solution. Analysis was carried out using the Wallac Victor<sup>2</sup> 1420 Multilabel Plate Reader (PerkinElmer, Melbourne, Australia) with excitation at 340 nm and emission at 613 nm.</p>
<a id="article1.body1.sec2.sec8.p2" name="article1.body1.sec2.sec8.p2"></a><p>Levels of the amyloid precursor protein (APP), the parent molecule of Aß, were quantitated by Western blot using the antibody 22C11 (Boehringer), which detects both the transgene-expressed human APP as well as the endogenous mouse APP. Briefly, snap-frozen tissues were thawed and homogenized in PBS (pH 7.4, 2 ml) and centrifuged at 100,000 g for 30 minutes. The pellet was resuspended 1:1000 (w/v) in PBS and aliquots dissolved by extensive boiling in 8% SDS sample buffer containing 10% mercaptoethanol prior to separation on PAGE.</p>
<a id="article1.body1.sec2.sec8.p3" name="article1.body1.sec2.sec8.p3"></a><p>Statistical analysis was carried out between genotypes using a non-parametric <em>t</em>-test (two-sided) (PRISM, Graphpad, San Diego, CA).</p>


<h4>ICP-MS evaluation of metal content of soluble and insoluble amyloid fractions</h4>
<a id="article1.body1.sec2.sec9.p1" name="article1.body1.sec2.sec9.p1"></a><p>Cortical samples were sonicated in 1 ml of PBS, centrifuged at 100,000 g for 30 minutes 4°C. The supernatant was collected and the pellet was resuspended in 1 ml of PBS.</p>
<a id="article1.body1.sec2.sec9.p2" name="article1.body1.sec2.sec9.p2"></a><p>A 500 µl aliquot of each brain pellet suspension was lyophilised. Samples were assayed by inductive-coupled plasma mass spectrometry according to our previously published procedures <a href="#pone.0000536-Maynard1">[35]</a>. Results are expressed as the average of the three triplicates in micrograms of metal per g of protein (µg/g). Note: The levels of cobalt and aluminium in the samples were below detectable levels. Statistical analysis was carried out between genotypes using a non-parametric <em>t</em>-test (two-sided).</p>

</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Results"></a><h3>Results</h3>
<h4>Mitochondrial oxidative stress causes hyperphosphorylation of tau</h4>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1"></a><p>To test whether mitochondrial oxidative stress causes hyperphosphorylation of tau, we studied <em>sod2</em> null mice that were treated with a catalytic antioxidant (EUK189). A low dose of EUK189 (1 mg/kg) rescues the peripheral phenotypes in these mice and extends the lifespan up to 3 weeks <a href="#pone.0000536-Melov1">[2]</a>, while revealing a spongiform encephalopathy <a href="#pone.0000536-Golden1">[14]</a> and severe behavioral disorder <a href="#pone.0000536-Melov1">[2]</a>. This treatment response is concordant when <em>sod2</em> null mice are treated with other closely related antioxidant regimens (EUK8, EUK134, analogues of EUK189, <a href="#pone.0000536-Melov1">[2]</a>). In contrast, treating <em>sod2</em> null mice with a high dose of EUK189 (30 mg/kg) improves survival, behavioral abnormalities, and transcriptional responses associated with oxidative stress, in conjunction with increasing activities of mitochondrial enzymes that are sensitive to mitochondrial oxidative stress <a href="#pone.0000536-Melov1">[2]</a>, <a href="#pone.0000536-Golden1">[14]</a>, as well as preventing spongiform neuropathology. <em>Sod2</em> null mice that are not treated with antioxidants die within the first week of life from peripheral organ failure without any observable brain pathology <a href="#pone.0000536-Li1">[5]</a>, <a href="#pone.0000536-Melov3">[11]</a>. Hence they are unsuitable to examine the effects of endogenous oxidative stress on the brain.</p>
<a id="article1.body1.sec3.sec1.p2" name="article1.body1.sec3.sec1.p2"></a><p>By comparing the low and high dose antioxidant treated groups of mice, we were able to contrast the effects of mitochondrial oxidative stress on the potential phosphorylation status of tau. Mice were killed (N = 6–8 per treatment group), frontal cortices were harvested, and protein was extracted and western blotted for quantification of tau and phosphorylated tau. To control for drug specific effects, wild-type mice were also treated with either low or high dose of EUK189 for the same period of time. Untreated <em>sod2</em> null mice on this genetic background do not survive long enough (&lt;1 week, <a href="#pone.0000536-Melov1">[2]</a>) to serve as a negative control.</p>
<a id="article1.body1.sec3.sec1.p3" name="article1.body1.sec3.sec1.p3"></a><p>First we asked whether lack of <em>sod2</em> caused an increase in the abundance of tau itself (<a href="#pone-0000536-g001">Figure 1A</a>). Two tailed non-parametric <em>t</em>-tests were carried out to determine differential levels of total tau in frontal cortices between <em>sod2</em> null mice and wild type controls. No significant differences were found between genotypes in either low (1 mg/kg) or high (30 mg/kg) EUK189 treated mice (<a href="#pone-0000536-g001">Figure 1A</a>). Next we asked if treatment with EUK189 within each genotype could have an effect on total tau levels. Interestingly, in wild type mice, there was a statistically significant drop in total tau (15%), as a result of increasing the concentration of EUK189 from 1 mg/kg to 30 mg/kg. In <em>sod2</em> null mice, the same trend was observed; increasing the dosage of EUK189 from 1 mg/kg to 30 mg/kg significantly decreased the total load of tau by 45%.</p>
<a id="article1.body1.sec3.sec1.p4" name="article1.body1.sec3.sec1.p4"></a><p>To determine whether lack of mitochondrial sod2 could alter the phosphorylation status of specific tau residues (Ser-396, Ser-404, Ser-214, Thr-231, and Thr-205), we normalized the amount of total tau per animal through a regression analysis (see <a href="#s2">methods</a>). Thus, we examined the level of phosphorylated tau at each of these residues without being confounded by the differential loads of tau seen between groups in <a href="#pone-0000536-g001">Figure 1A</a>. Treatment with EUK189 has no effect on phospho-tau epitopes in wild type controls, however EUK189 normalized phospho-tau epitopes in the <em>sod2</em> mutant mice (<a href="#pone-0000536-g001">Figure 1</a>).</p>
<a id="article1.body1.sec3.sec1.p5" name="article1.body1.sec3.sec1.p5"></a><p><a href="#pone-0000536-g001">Figure 1B</a> shows that in the low dose treated <em>sod2</em> null mice, there is a most prominent 7-fold increase in the hyperphosphorylation of tau at Thr-205 in <em>sod2</em> null compared to wild type mice (<em>p</em>&lt;0.001). There is also a trend for reduced phosphorylation of Thr-205 due to a higher dose of antioxidant treatment, although this does not reach statistical significance (<a href="#pone-0000536-g001">Figure 1B</a>).</p>
<a id="article1.body1.sec3.sec1.p6" name="article1.body1.sec3.sec1.p6"></a><p><a href="#pone-0000536-g001">Figure 1C</a> shows that lack of <em>sod2</em> causes a more than 2-fold significant increase in the level of hyperphosphorylation of Ser-396 (<em>p</em>&lt;0.001) over treatment-matched controls, and that increasing the dose of antioxidant significantly attenuates the level of hyperphosphorylation (<em>p</em> = 0.02). Similarly, for Ser-404, mitochondrial oxidative stress also increases the level of hyperphosphorylation of tau to 3-fold over treated controls (<a href="#pone-0000536-g001">Figure 1D</a>, <em>p</em>&lt;0.001), while increasing the dosage of antioxidant to reduce oxidative stress rescues the hyperphosphorylation to wild-type levels (<em>p</em>&lt;0.04). Ser-214 is the only phospho-tau epitope that was hypo-phosphorylated in the low dose <em>sod2</em> null mice (<em>p</em>&lt;0.001), with increased dose of antioxidant again normalizing the level of hypophosphorylation to wild-type levels (<a href="#pone-0000536-g001">Figure 1E</a>). <a href="#pone-0000536-g001">Figure 1F</a> shows an increase in the phosphorylation of Thr-231 (1.3 fold, p = 0.004) in the low-dose EUK-189 treated <em>sod2</em> null animals, which is correspondingly rescued with high-dose EUK-189 antioxidant treatment (p = 0.004). Finally we asked if there were any sex specific effects with regard to differential phospho-tau loads between treatment groups, and there were no significant trends detected (data not shown).</p>
<a id="article1.body1.sec3.sec1.p7" name="article1.body1.sec3.sec1.p7"></a><p>In order to validate our initial observations of hyperphosphorylation of tau at residues associated with AD in <em>sod2</em> null mice, we employed mass-spectrometry techniques as an alternate approach. To maximize the likelihood of detecting multiple sites of phosphorylation of tau, we immunoprecipitated total tau protein from <em>sod2</em> null (treated with 1 mg/kg EUK189) mice using the Tau-5 monoclonal antibody, which detects both phosphorylated and non-phosphorylated forms of tau (Biosource). After releasing tau from the antibody, the protein was reduced, alkylated and digested with trypsin (see <a href="#s2">methods</a>). Peptides were analyzed by MALDI TOF MS for peptide mass fingerprint analysis, then nano-HPLC-ESI-MS/MS. To determine site(s) of phosphorylation within tau protein the ESI-MS/MS spectra were searched by Mascot, and spectra shown to contain phosphorylated peptides were verified by manual inspection. Our mass spectrometric results corresponded with the positive phospho-antibody probing of tau for phosphorylation sites shown in <a href="#pone-0000536-g001">Figure 1</a>, such as phospho Ser-404, phospho Thr-231, and phospho Ser-396 (as determined by ESI-MS/MS and ESI-MS). The tryptic peptides covering phosphorylation site phospho Thr-205 clearly showed mono- and diphosphorylation events, but due to the complex assembly of potential serine and threonine residues the mass spectrometric studies could not provide unambiguous assignment of Thr-205 as the phosphorylation site. Additional data seen in our mass-spec data provided clear evidence for the site of phosphorylation of phospho Thr-181 and phospho Ser-159, two well-characterized sites of phosphorylation of tau in AD <a href="#pone.0000536-Augustinack1">[32]</a>. <a href="#pone-0000536-t001">Table 1</a> shows the range of sites identified by mass spectrometry in brain tissue isolated from <em>sod2</em> null mice.</p>
<div class="figure" id="pone-0000536-t001"><div class="img"><a name="pone-0000536-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000536.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000536.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>Tau phosphorylation sites identified in <em>sod2</em> null mouse brain tissue</span></strong></p><span>doi:10.1371/journal.pone.0000536.t001</span></div><a id="article1.body1.sec3.sec1.p8" name="article1.body1.sec3.sec1.p8"></a><p>We next investigated whether pathological sequelae associated with hyperphosphorylation of tau in AD were also present in brain sections from <em>sod2</em> null mice. We used a modified Gallyas stain to detect possible neurofibrillary tangles (NFTs) in tissue sections (<a href="#s2">methods</a>). We also used Schiff staining to determine if any other pathology related to AD, such as insoluble amyloid plaques were also present <a href="#pone.0000536-Bancroft1">[36]</a>. We were unable to identify any pathology relating to NFTs or aberrant amyloid metabolism using either of these methods in sections throughout the brain from 3-week-old <em>sod2</em> null mice on either low or high dose EUK189 (data not shown).</p>


<h4>Mitochondrial oxidative stress increases phosphorylation of tau in Tg2576:<em>sod2</em> mice</h4>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1"></a><p>Having determined that mitochondrial oxidative stress causes hyperphosphorylation of tau, and that this can be ameliorated by antioxidant treatment, we next asked if there might be a synergistic interplay between aberrant amyloid metabolism and mitochondrial oxidative stress. Therefore, we crossed the Tg2576 (APP) mouse to hemizygous <em>sod2</em> mice to create Tg2576:<em>sod2</em> mice as described above. These double mutant mice are on an identical genetic background to Tg2576 mice. Therefore we aged four female genetically distinct groups (Tg2576, Tg2576:<em>sod2</em>, <em>sod2</em>+/−, and wild-type controls) on the same genetic background as the Tg2576 mice (F1 C57BL/6J: SJL hybrids), to approximately 16 months of age (when brain amyloid pathology is uniformly well-established in the Tg2576 model <a href="#pone.0000536-Hsiao1">[20]</a>) in order to investigate the effects of increased mitochondrial oxidative stress on amyloid and potential tau pathology. No difference in survival between the 4 groups was observed up to this age. The animals were sacrificed and the brains harvested, with half the brain being fixed and paraffin embedded for histological studies, while cortex from the other half was snap frozen for biochemical studies. Protein was extracted and equivalent amounts of protein from the 4 genetic groups were evaluated for levels of phospho Ser-396, a widely used epitope for detecting NFTs in AD, and readily induced in the brains of <em>sod2</em> null mice compared to controls (<a href="#pone-0000536-g001">Figure 1</a>).</p>
<a id="article1.body1.sec3.sec2.p2" name="article1.body1.sec3.sec2.p2"></a><p>Levels of phospho Ser-396 in <em>sod2</em>+/− and Tg2576 mice were not significantly different from WT mice, indicating that oxidative stress induced by either loss of 50% <em>sod2</em> activity <a href="#pone.0000536-VanRemmen1">[9]</a> or cerebral β-amyloid <a href="#pone.0000536-Opazo1">[19]</a>, was insufficient to impact levels of Ser-396 phosphorylation. However, we detected a significant 45% increase in the levels of phospho Ser-396 (<em>p</em>&lt;0.003) in Tg2576:<em>sod2</em> over the levels in Tg2576 or <em>sod2</em>+/− alone (<a href="#pone-0000536-g002">Figure 2</a>). This is consistent with synergy between amyloid load and increased mitochondrial oxidative stress in the hyperphosphorylation of tau.</p>
<div class="figure" id="pone-0000536-g002"><div class="img"><a name="pone-0000536-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>Mitochondrial oxidative stress results in a synergistic increase in the levels of phospho-tau in Tg2576 mice.</span></strong></p><a id="article1.body1.sec3.sec2.fig1.caption1.p1" name="article1.body1.sec3.sec2.fig1.caption1.p1"></a><p>Data show the mean±SD levels of Ser-396 phospho-tau assayed by Western blot of cortical extracts from mice of ≈500 days of age from each of the following genotypes: wild-type n = 4, <em>sod2</em>+/−n = 4, Tg2576 n = 8, Tg2576:<em>sod2</em> n = 9 (all matched for genetic background). A non parametric t test was carried out between genotypes, and a significant increase in phospho tau in the Tg2576:<em>sod2</em> mice was observed, compared to controls.</p>
<span>doi:10.1371/journal.pone.0000536.g002</span></div><a id="article1.body1.sec3.sec2.p3" name="article1.body1.sec3.sec2.p3"></a><p>Sections from fixed hemispheres of the same animals where Ser-396 phospho-tau levels were assayed in <a href="#pone-0000536-g002">Figure 2</a> were stained for phospho Ser-396. In contrast to non-transgenic <em>sod2</em> null mice, we detected dystrophic neurites positive for phospho tau (<a href="#pone-0000536-g003">Figure 3</a>), in a pattern previously reported to be associated with plaque pathology <a href="#pone.0000536-Dewachter1">[37]</a>. Absorption with the peptide specific for the phospho Ser-396 epitope abolished detectable signal (<a href="#pone-0000536-g003">Figure 3B</a>.). Comparison of IHC for Ser-396 between Tg2576 and Tg2576:<em>sod2</em> mice (n = 3 each) revealed no qualitative or quantitative differences between the groups at the immunohistochemical level for hyperphosphorylated tau and no neurofibrillary tangles.</p>
<div class="figure" id="pone-0000536-g003"><div class="img"><a name="pone-0000536-g003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g003.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 3.  <span>Immunohistochemical identification of phospho-tau positive dystrophic neurites in Tg2576:<em>sod2</em> mice.</span></strong></p><a id="article1.body1.sec3.sec2.fig2.caption1.p1" name="article1.body1.sec3.sec2.fig2.caption1.p1"></a><p>(a) Immunohistochemistry for anti Ser-396 was carried out as described in the text, and positivity was observed surrounding senile plaques in the brains of Tg2576:<em>sod2</em> mice. (b) In order to ensure specificity, we also tested the effects of preadsorbing the Ser-396 antibody with the peptide the antibody was raised against. This abolished the staining seen around the plaques.</p>
<span>doi:10.1371/journal.pone.0000536.g003</span></div>

<h4>Oxidative stress modulation is linked to Aß levels in Tg2576 mice</h4>
<a id="article1.body1.sec3.sec3.p1" name="article1.body1.sec3.sec3.p1"></a><p>We next investigated the effect of <em>sod2</em> deficiency and Euk189 treatment upon brain Aß burden in APP transgenic mice.</p>
<a id="article1.body1.sec3.sec3.p2" name="article1.body1.sec3.sec3.p2"></a><p>We used two different methods to test this hypothesis; we evaluated Aß plaque load by immunohistochemistry and also assessed Aß protein by ELISA in each of the different treatment groups (Tg2576+EUK189, Tg2576, Tg2576:<em>sod2</em>). The immunohistochemistry data (<a href="#pone-0000536-g004">Figure 4</a>) indicate that the Tg2576:<em>sod2</em> animals have a 32% and a 29% increase in plaque burden as compared to Tg2576+EUK189 and Tg2576 animals respectively, which does not reach statistical significance (p = 0.18, p = 0.22). The ELISA data (<a href="#pone-0000536-g004">Figure 4</a>) demonstrates that Tg2576 and Tg2576:<em>sod2</em> animals have a 73% (p = 0.01) and 52% (p = 0.3) increase in total Aß1-40 and a 172% (p = 0.04) and 265% (p = 0.02) increase in total Aß1-42 respectively, as compared to Tg2576+EUK189 animals. Tg2576:<em>sod2</em> animals also show a 12% decrease in total Aß1-40 and a 34% increase in total Aß1-42 as compared to Tg2576 mice. These findings indicate that while the <em>sod2</em> mutant allele did not have a discernable effect on total Aß levels, the antioxidant treatment did drop Aß levels significantly.</p>
<div class="figure" id="pone-0000536-g004"><div class="img"><a name="pone-0000536-g004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g004.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 4.  <span>Exacerbation of amyloid load by genetic combination of lack of <em>sod2</em> and overexpression of APP.</span></strong></p><a id="article1.body1.sec3.sec3.fig1.caption1.p1" name="article1.body1.sec3.sec3.fig1.caption1.p1"></a><p>(a) Immunohistochemistry quantitation (area occupied by Aß/mm2) did not demonstrate any significant alterations in total Aß plaque burden, although there is an ~30% increase (p = 0.2) in plaques in the Tg2576:<em>sod2</em> animals as compared to other groups. (b) ELISA quantitation demonstrates that EUK189 treatment significantly modulates Aß levels. Furthermore, genetically combining lack of <em>sod2</em> with overexpression of mutant APP elevates Aß levels in the Tg2576 mouse. The data indicate mean±SD.</p>
<span>doi:10.1371/journal.pone.0000536.g004</span></div><a id="article1.body1.sec3.sec3.p3" name="article1.body1.sec3.sec3.p3"></a><p>The precursor to Aß, the amyloid precursor protein (APP), also showed significant modulation according to genotype. As shown in <a href="#pone-0000536-g005">Figure 5</a>, the <em>sod2</em> mutation present in the Tg2576:<em>sod2</em> animals resulted in a significant elevation (87%, p = 0.002) in total APP levels as compared to the Tg2576 background strain and a 47% (p = 0.02) increase compared to Tg2576 mice treated with EUK189.</p>
<div class="figure" id="pone-0000536-g005"><div class="img"><a name="pone-0000536-g005" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g005&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g005"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g005&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g005/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g005/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g005/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g005/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g005.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g005/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g005/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g005.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 5.  <span>APP levels are elevated by genetic combination of <em>sod2</em> with Tg2576 mice.</span></strong></p><a id="article1.body1.sec3.sec3.fig2.caption1.p1" name="article1.body1.sec3.sec3.fig2.caption1.p1"></a><p>The data indicate mean±SD APP levels in brain assayed by western blot. As compared to the baseline Tg2576 levels, APP protein was marginally higher in Tg2576 mice treated with EUK189 (29% increased, p = 0.2), but markedly elevated by the presence of the sod2 mutation (88% increased, p = 0.002).</p>
<span>doi:10.1371/journal.pone.0000536.g005</span></div>

<h4>Decreased metal content in Tg2576:<em>sod2</em> mice</h4>
<a id="article1.body1.sec3.sec4.p1" name="article1.body1.sec3.sec4.p1"></a><p>Because APP overexpression lowers cellular copper <a href="#pone.0000536-Bellingham1">[38]</a>, <a href="#pone.0000536-Maynard2">[39]</a> and decreased copper levels exacerbates amyloid pathology <a href="#pone.0000536-Bayer1">[40]</a>, <a href="#pone.0000536-Phinney1">[41]</a>, we investigated whether the synergistic interplay between <em>sod2</em> ablation and Alzheimer pathology in Tg2576 transgenics is reflected by lowered brain metal levels.</p>
<a id="article1.body1.sec3.sec4.p2" name="article1.body1.sec3.sec4.p2"></a><p>As shown in <a href="#pone-0000536-g006">Figure 6</a>, there is a decrease in copper levels in both the supernatant (25%, p = 0.01) and pellet (16%, p = 0.02) brain fractions of Tg2576:<em>sod2</em> animals as compared to the Tg2576 background strain. Similarly, there is a significant decrease in manganese levels in both the pellet (23%, p = 0.01) and supernatant (35%, p = 0.0002) fractions of Tg2576:<em>sod2</em> animals as compared to the background Tg2576 mice. There is also a significant increase in manganese levels in the EUK189 treated Tg2576 mice, as compared to the Tg2576 background strain, in both the pellet (113%, p = 0.002) and supernatant (91%, p = 0.0002) fractions. Similar trends are also shown for zinc, which shows a significant decrease in pellet (21%, p = 0.001) and supernatant (18%, p = 0.02) levels in the Tg2576:<em>sod2</em> animals as compared to the background Tg2576 mice. We also found a significant increase in supernatant zinc levels (12%, p = 0.05) in the EUK189-treated Tg2576 animals as compared to the background Tg2576 mice.</p>
<div class="figure" id="pone-0000536-g006"><div class="img"><a name="pone-0000536-g006" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g006&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g006"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g006&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g006/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g006/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g006/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g006/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g006.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g006/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g006/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g006.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 6.  <span>Metal levels are lowered by genetic combination of lack of <em>sod2</em> and overexpression of APP.</span></strong></p><a id="article1.body1.sec3.sec4.fig1.caption1.p1" name="article1.body1.sec3.sec4.fig1.caption1.p1"></a><p>Data indicate mean±SD brain metal levels in the various genotypes, as indicated. This revealed a significant decrease in insoluble (16%) (A) and soluble (25%) (B) Copper levels, insoluble (23%) (C) and soluble (35%) (D) Manganese levels, and insoluble (21%) (E) and soluble (18%) (F) Zinc levels in the Tg2576:<em>sod2</em> animals compared to the Tg2576 background strain. EUK189 treatment increased soluble (91%) and insoluble (113%) Manganese and soluble (12%) Zinc levels in the Tg2576 animals.</p>
<span>doi:10.1371/journal.pone.0000536.g006</span></div><a id="article1.body1.sec3.sec4.p3" name="article1.body1.sec3.sec4.p3"></a><p>Consistent with previous reports <a href="#pone.0000536-Bellingham1">[38]</a>–<a href="#pone.0000536-Phinney1">[41]</a> and with an interaction of copper in our experimental system, we found that there is a significant inverse correlation between brain APP levels and both pellet (p = 0.0005) and supernatant (p = 0.02) copper levels (<a href="#pone-0000536-g007">Figure 7</a>) in the untreated transgenic mice. This implies that the decreased Cu levels in the APP:<em>sod2</em> double mutants (<a href="#pone-0000536-g006">Figure 6A&amp;B</a>) are caused by elevated APP expression.</p>
<div class="figure" id="pone-0000536-g007"><div class="img"><a name="pone-0000536-g007" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g007&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g007"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g007&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g007/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g007/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g007/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g007/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g007.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g007/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g007/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g007.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 7.  <span>APP vs. copper correlation.</span></strong></p><a id="article1.body1.sec3.sec4.fig2.caption1.p1" name="article1.body1.sec3.sec4.fig2.caption1.p1"></a><p>Levels of APP and Copper in the soluble and pellet phases of brain homogenate from untreated Tg2576 and Tg2576:<em>sod2</em> crossed mice (pooled) were compared graphically and found to correlate strongly (* p&lt;0.02).</p>
<span>doi:10.1371/journal.pone.0000536.g007</span></div><a id="article1.body1.sec3.sec4.p4" name="article1.body1.sec3.sec4.p4"></a><p>There was a marked decrease in the levels of Mn in both pellet and supernatant fractions of the Tg2576:<em>sod2</em> mice compared to the control Tg2576 mice. SOD2 is a homotetramer requiring Mn for its catalytic activity. Our observations of a 23–35% decrease in Mn in both the pellet and supernatant fractions from the brains of Tg2576:<em>sod2</em> mice compared to controls is consistent with the loss of SOD2. We also observed a 91–113% increase in the levels of Mn in the brains of mice treated with EUK189, which is a Mn-containing catalytic antioxidant. This is consistent with EUK189 or its bound Mn accumulating within the brain.</p>

</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1"></a><p>Mitochondria are the chief source of ROS within the cell, and age-related oxidative damage in the brain has been associated with neurodegenerative diseases such as Alzheimer's and Parkinson's diseases <a href="#pone.0000536-Barnham1">[15]</a>. We tested the hypothesis that mitochondrial oxidative stress could contribute to the two pathological hallmarks of AD, amyloid burden and hyperphosphorylation of tau. We initially evaluated the brains of 3-week old <em>sod2</em> null animals treated with low and high doses of the catalytic antioxidant, EUK-189. These mice would die within the first week of life unless treated with antioxidants <a href="#pone.0000536-Melov1">[2]</a>. We previously developed the paradigm of treating <em>sod2</em> null mice with differential doses of catalytic antioxidants, whereby at a low dose of treatment (1 mg/kg of catalytic antioxidant), the peripheral phenotypes are rescued and lifespan is extended, but a severe spongiform pathology with neurodegeneration develops by 3-weeks-of-age <a href="#pone.0000536-Hinerfeld1">[12]</a>. At high doses of catalytic antioxidant (30 mg/kg), the spongiform pathology is completely prevented, and the accompanying neurodegeneration is attenuated <a href="#pone.0000536-Melov1">[2]</a>, <a href="#pone.0000536-Hinerfeld1">[12]</a>. Thus, we could compare the changes in amyloid/tau in the brains of wild-type and <em>sod2</em>−/− mice treated with low and high doses of antioxidant (<a href="#pone-0000536-g001">Figure 1</a>) in order to test the hypothesis that oxidative stress from mitochondrial dysfunction promotes AD-like pathology.</p>
<a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2"></a><p>We did not find evidence of increased amyloid burden in <em>sod2</em> nullizygous neonatal mice, possibly because endogenous mouse Aß has three amino acid substitutions that prevent mouse Aß from being precipitated by synaptic copper and zinc <a href="#pone.0000536-Bush1">[42]</a>. However, we did find a striking increase in the levels of hyperphosphorylated tau at 3 weeks of age, which responded to catalytic antioxidant therapy (<a href="#pone-0000536-g001">Figure 1</a>).</p>
<a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3"></a><p>We observed a significant increase in the level of hyperphosphorylation in 4 out of 5 specific residues evaluated compared to control wild-type animals (<a href="#pone-0000536-t001">Table 1</a>). We did observe one residue (Ser-214) that was hypophosphorylated in response to mitochondrial oxidative stress. The phosphorylation status of various residues in tau results from a complex interplay between the inhibition and activation of kinases and phosphatases specific for individual residues. A recent report shows that a peptidyl-prolyl cis/trans isomerase (Pin1) caused hypophosphorylation of Thr-231, Thr-212, Ser-396, and Ser-404 in response to an extracellular hydrogen peroxide stress in primary neuronal cultures isolated from neonatal rats<a href="#pone.0000536-Galas1">[43]</a>. Hence, extracellular oxidative stress can cause hypophosphorylation of specific residues in tau. In contrast, we show here that intracellular oxidative stress appears to cause hyperphosphorylation in most residues we studied (<a href="#pone-0000536-t001">table 1</a>). Each of these hyperphosphorylated residues has been previously associated with aggregated hyperphosphorylated tau in AD <a href="#pone.0000536-Augustinack1">[32]</a>, and in the high-dose treated <em>sod2</em> null animals, we observed a significant normalization of phosphorylation toward wild-type levels of phosphorylation in 3 out of 4 residues which were hyperphosphorylated (<a href="#pone-0000536-g001">Figure 1</a>). Thr-205 did not reach significance (although a trend consistent with the other three residues was apparent), possibly due to more noise in this particular group. Overall, we conclude that hyperphosphorylated tau which is caused by mitochondrial oxidative stress could be resolved with appropriate antioxidant therapy.</p>
<a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4"></a><p>A number of prior studies have found associations between mitochondrial dysfunction and AD, and animal models of AD <a href="#pone.0000536-Esposito1">[26]</a>, <a href="#pone.0000536-Blass1">[44]</a>–<a href="#pone.0000536-Smith2">[46]</a>. Aß inhibits mitochondrial alcohol dehydrogenase <a href="#pone.0000536-Lustbader1">[47]</a>, <a href="#pone.0000536-Takuma1">[48]</a> and cytochrome oxidase <a href="#pone.0000536-Crouch1">[49]</a> leading to increased mitochondrial oxidative stress and apoptosis <a href="#pone.0000536-Lustbader1">[47]</a>. A recent report also demonstrated a 9–11 fold increase in the expression of SOD2 by immunohistochemistry in the hippocampus of Alzheimer patients compared to controls, indicating a possible upregulation of antioxidant defenses in response to a pro-oxidant environment within the brain of AD patients <a href="#pone.0000536-Marcus1">[50]</a>. To investigate the consequences of increased mitochondrial oxidative stress in the context of an established mouse model of AD, we crossed the Tg2576 mouse to mice heterozygous for <em>sod2</em>, a model of mild mitochondrial oxidative stress <a href="#pone.0000536-VanRemmen1">[9]</a>, <a href="#pone.0000536-VanRemmen2">[51]</a>, <a href="#pone.0000536-VanRemmen3">[52]</a>. Concomitant with our observations of increased hyperphosphorylation of tau as a consequence of <em>sod2</em> knockout as described above (<a href="#pone-0000536-g001">Figure 1</a>), we investigated the levels of Ser-396 phospho-tau, which is characteristically elevated in AD <a href="#pone.0000536-Augustinack1">[32]</a>, in the brains of double mutant mice compared to controls. We found a robust increase in the levels of phospho Ser-396 as a consequence of increased mitochondrial oxidative stress, above and beyond that seen in either parental control line, Tg2576 mice alone, or <em>sod2</em> heterozygotes (<a href="#pone-0000536-g002">Figure 2</a>). This implies that there is a synergistic interplay between mitochondrial dysfunction and amyloid burden that leads to hyperphosphorylation of tau. We also found a relationship between the level of oxidative stress and the level of amyloid burden (<a href="#pone-0000536-g004">Figure 4</a>). A recent report also found evidence of oxidative stress being linked to tau-mediated neurodegeneration in <em>drosophila</em> <a href="#pone.0000536-DiasSantagata1">[53]</a>.</p>
<a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5"></a><p>The trends we observed, of increased amyloid burden (<a href="#pone-0000536-g004">Figure 4A</a>) and Aß42 (<a href="#pone-0000536-g004">Figure 4C</a>) as a result of <em>sod2</em> heterozygosity, is consistent with a previous report where amyloid load was increased by approximately 2 fold compared to controls through genetic combination of <em>sod2</em> heterozygotes with the Tg19959 model of AD <a href="#pone.0000536-Li2">[27]</a>. However, a more recent report observed decreased plaque burden in the parenchyma, with increased vascular amyloid, gliosis and exaggerated neurocognitive deficits as a consequence of <em>sod2</em> heterozygosity in J20 APP transgenic mice <a href="#pone.0000536-Esposito1">[26]</a>. It is worth noting that Esposito et al., also found enhanced loss of microtubule-dependant protein 2 (MAP2) that was APP/Aß dependant in their <em>sod2</em>/APP model (which differs from the model we report here). MAP2 is involved in maintaining microtubule integrity like tau, and depletion of MAP2 is often observed in association with hypephosphorylation of tau<a href="#pone.0000536-Li3">[54]</a>. Hence it is possible that the J20 APP/<em>sod2</em> mice<a href="#pone.0000536-Esposito1">[26]</a>, may also be experiencing hyperphosphorylation of tau, given the reported apparent loss of MAP2 in in the brains of these mice. Collectively, these three studies (<a href="#pone.0000536-Esposito1">[26]</a>, <a href="#pone.0000536-Li2">[27]</a>, and the data we report here) confirm that the SOD2 allele impacts upon AD-like pathology, but clearly the effects vary according to the AD mouse model utilized. Our study is the first to describe an association between SOD2 knockout or antioxidant-modulated oxidative stress and tau phosphorylation, which has not been investigated previously.</p>
<a id="article1.body1.sec4.p6" name="article1.body1.sec4.p6"></a><p>Previous studies have demonstrated that copper and iron levels in the brains of transgenic mice are lowered by expressing mutant APP or the carboxyl terminus of APP <a href="#pone.0000536-Maynard2">[39]</a>–<a href="#pone.0000536-Phinney1">[41]</a>. Consistent with metal deficiency fostering amyloid accumulation, we have previously found that amyloid clearance induced by clioquinol is associated with an elevation of cortical zinc and copper in the brains of Tg2576 mice <a href="#pone.0000536-Cherny1">[55]</a>. Our current findings indicate that brain Cu, Zn, Fe, and Mn levels are all decreased as a consequence of genetic combination of Tg2576 and <em>sod2</em> heterozygotes. While the significance of this finding is not clear, these metals all participate in essential cellular function. It is likely that the drop in energy that results from the mitochondrial damage leads to a loss of brain metals. Decreased intracellular copper levels may exacerbate amyloid pathology <a href="#pone.0000536-Bayer1">[40]</a>, <a href="#pone.0000536-Phinney1">[41]</a> by a mechanism that is not yet clear. Therefore, the drop in brain copper levels induced by the Tg2576:<em>sod2</em> double mutation may contribute to the increased amyloid burden in double mutants.</p>
<a id="article1.body1.sec4.p7" name="article1.body1.sec4.p7"></a><p>In summary, we have shown that mitochondrial oxidative stress per se causes hyperphosphorylation of tau, and that this can be prevented through appropriate antioxidant treatment (<a href="#pone-0000536-g008">Figure 8</a>). We have also demonstrated that the aggregate amyloid burden in a well established mouse model of AD (the Tg2576 mouse) is influenced by mitochondrial oxidative stress. This has implications for how we view mouse models of AD, in that to our knowledge, this is the first mouse model of AD that recapitulates two of the canonical hallmarks of AD pathology: plaques, and hyperphosphorylated tau, without resorting to overexpression of both mutant human proteins. Hyperphosphorylated tau is a component of neurofibrillary tangles, the formation of which is closely associated with the dementia process in AD. These findings encourage the use of ROS-scavenging antioxidants as being of potential therapeutic utility in AD.</p>
<div class="figure" id="pone-0000536-g008"><div class="img"><a name="pone-0000536-g008" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g008&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000536" data-uri="info:doi/10.1371/journal.pone.0000536.g008"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000536.g008&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g008/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g008/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g008/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g008/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g008.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000536.g008/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000536.g008/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000536.g008.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 8.  <span>Model of potential interactions between increasing Aß, decreased activity of SOD2, and a resultant increase in the hyperphosphorylation of tau.</span></strong></p><a id="article1.body1.sec4.fig1.caption1.p1" name="article1.body1.sec4.fig1.caption1.p1"></a><p>As levels of Aß increase with age, this causes a concomitant decrease in the activity of SOD2, which in turn leads to increased aggregation of Aß. The resulting pro-oxidant state of the cell causes hyperphosphorylation of tau.</p>
<span>doi:10.1371/journal.pone.0000536.g008</span></div></div>



<div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: SM DH AB. Performed the experiments: SM TG BS BG IV RC PA KM FJ DH CM QL KL. Analyzed the data: SM TG AH BS BG IV RC PA KM FJ DH CM QL KL AB. Contributed reagents/materials/analysis tools: SM BG CM AB. Wrote the paper: SM TG AH BG PA KM AB.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0000536-Strassburger1" id="pone.0000536-Strassburger1"></a>Strassburger M, Bloch W, Sulyok S, Schuller J, Keist AF, et al.  (2005) Heterozygous deficiency of manganese superoxide dismutase results in severe lipid peroxidation and spontaneous apoptosis in murine myocardium in vivo. Free Radical Biology and Medicine  38: 1458–1470.  <ul class="find" data-citedArticleID="959452" data-doi="10.1016/j.freeradbiomed.2005.02.009"><li><a href="http://dx.doi.org/10.1016/j.freeradbiomed.2005.02.009" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Heterozygous+deficiency+of+manganese+superoxide+dismutase+results+in+severe+lipid+peroxidation+and+spontaneous+apoptosis+in+murine+myocardium+in+vivo." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Heterozygous+deficiency+of+manganese+superoxide+dismutase+results+in+severe+lipid+peroxidation+and+spontaneous+apoptosis+in+murine+myocardium+in+vivo.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0000536-Melov1" id="pone.0000536-Melov1"></a>Melov S, Doctrow SR, Schneider JA, Haberson J, Patel M, et al.  (2001) Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. Journal of Neuroscience  21: 8348–8353.  <ul class="find" data-citedArticleID="959382"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Lifespan+extension+and+rescue+of+spongiform+encephalopathy+in+superoxide+dismutase+2+nullizygous+mice+treated+with+superoxide+dismutase-catalase+mimetics.&amp;auth=&amp;atitle=Lifespan+extension+and+rescue+of+spongiform+encephalopathy+in+superoxide+dismutase+2+nullizygous+mice+treated+with+superoxide+dismutase-catalase+mimetics." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Lifespan+extension+and+rescue+of+spongiform+encephalopathy+in+superoxide+dismutase+2+nullizygous+mice+treated+with+superoxide+dismutase-catalase+mimetics." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Lifespan+extension+and+rescue+of+spongiform+encephalopathy+in+superoxide+dismutase+2+nullizygous+mice+treated+with+superoxide+dismutase-catalase+mimetics.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0000536-Melov2" id="pone.0000536-Melov2"></a>Melov S, Schneider JA, Day BJ, Hinerfeld D, Coskun P, et al.  (1998) A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nature Genetics  18: 159–163.  <ul class="find" data-citedArticleID="959440" data-doi="10.1038/ng0298-159"><li><a href="http://dx.doi.org/10.1038/ng0298-159" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+novel+neurological+phenotype+in+mice+lacking+mitochondrial+manganese+superoxide+dismutase." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+novel+neurological+phenotype+in+mice+lacking+mitochondrial+manganese+superoxide+dismutase.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0000536-Qi1" id="pone.0000536-Qi1"></a>Qi X, Lewin AS, Hauswirth WW, Guy J (2003) Optic neuropathy induced by reductions in mitochondrial superoxide dismutase. Investigative Ophthalmology and Visual Science  44: 1088–1096.  <ul class="find" data-citedArticleID="959416" data-doi="10.1167/iovs.02-0864"><li><a href="http://dx.doi.org/10.1167/iovs.02-0864" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Optic+neuropathy+induced+by+reductions+in+mitochondrial+superoxide+dismutase." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Optic+neuropathy+induced+by+reductions+in+mitochondrial+superoxide+dismutase.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0000536-Li1" id="pone.0000536-Li1"></a>Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, et al.  (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genetics  11: 376–381.  <ul class="find" data-citedArticleID="959438" data-doi="10.1038/ng1295-376"><li><a href="http://dx.doi.org/10.1038/ng1295-376" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Dilated+cardiomyopathy+and+neonatal+lethality+in+mutant+mice+lacking+manganese+superoxide+dismutase." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Dilated+cardiomyopathy+and+neonatal+lethality+in+mutant+mice+lacking+manganese+superoxide+dismutase.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0000536-Huang1" id="pone.0000536-Huang1"></a>Huang TT, Carlson EJ, Kozy HM, Mantha S, Goodman SI, et al.  (2001) Genetic modification of prenatal lethality and dilated cardiomyopathy in Mn superoxide dismutase mutant mice. Free Radical Biology and Medicine  31: 1101–1110.  <ul class="find" data-citedArticleID="959426" data-doi="10.1016/s0891-5849(01)00694-3"><li><a href="http://dx.doi.org/10.1016/s0891-5849(01)00694-3" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Genetic+modification+of+prenatal+lethality+and+dilated+cardiomyopathy+in+Mn+superoxide+dismutase+mutant+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Genetic+modification+of+prenatal+lethality+and+dilated+cardiomyopathy+in+Mn+superoxide+dismutase+mutant+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0000536-Friedman1" id="pone.0000536-Friedman1"></a>Friedman JS, Rebel VI, Derby R, Bell K, Huang TT, et al.  (2001) Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. Journal of Experimental Medicine  193: 925–934.  <ul class="find" data-citedArticleID="959390" data-doi="10.1084/jem.193.8.925"><li><a href="http://dx.doi.org/10.1084/jem.193.8.925" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Absence+of+mitochondrial+superoxide+dismutase+results+in+a+murine+hemolytic+anemia+responsive+to+therapy+with+a+catalytic+antioxidant." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Absence+of+mitochondrial+superoxide+dismutase+results+in+a+murine+hemolytic+anemia+responsive+to+therapy+with+a+catalytic+antioxidant.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0000536-Friedman2" id="pone.0000536-Friedman2"></a>Friedman JS, Lopez MF, Fleming MD, Rivera A, Martin FM, et al.  (2004) SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood  104: 2565–2573.  <ul class="find" data-citedArticleID="959378" data-doi="10.1182/blood-2003-11-3858"><li><a href="http://dx.doi.org/10.1182/blood-2003-11-3858" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=SOD2-deficiency+anemia%3A+protein+oxidation+and+altered+protein+expression+reveal+targets+of+damage%2C+stress+response%2C+and+antioxidant+responsiveness." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22SOD2-deficiency+anemia%3A+protein+oxidation+and+altered+protein+expression+reveal+targets+of+damage%2C+stress+response%2C+and+antioxidant+responsiveness.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0000536-VanRemmen1" id="pone.0000536-VanRemmen1"></a>Van Remmen H, Ikeno Y, Hamilton M, Pahlavani M, Wolf N, et al.  (2003) Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics  16: 29–37.  <ul class="find" data-citedArticleID="959368" data-doi="10.1152/physiolgenomics.00122.2003"><li><a href="http://dx.doi.org/10.1152/physiolgenomics.00122.2003" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Life-long+reduction+in+MnSOD+activity+results+in+increased+DNA+damage+and+higher+incidence+of+cancer+but+does+not+accelerate+aging." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Life-long+reduction+in+MnSOD+activity+results+in+increased+DNA+damage+and+higher+incidence+of+cancer+but+does+not+accelerate+aging.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0000536-Samper1" id="pone.0000536-Samper1"></a>Samper E, Nicholls DG, Melov S (2003) Mitochondrial oxidative stress causes chromosomal instability of mouse embryonic fibroblasts. Aging Cell  2: 277–285.  <ul class="find" data-citedArticleID="959392" data-doi="10.1046/j.1474-9728.2003.00062.x"><li><a href="http://dx.doi.org/10.1046/j.1474-9728.2003.00062.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mitochondrial+oxidative+stress+causes+chromosomal+instability+of+mouse+embryonic+fibroblasts." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mitochondrial+oxidative+stress+causes+chromosomal+instability+of+mouse+embryonic+fibroblasts.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0000536-Melov3" id="pone.0000536-Melov3"></a>Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, et al.  (1999) Mitochondrial disease in superoxide dismutase 2 mutant mice. Proceedings of the National Academy of Sciences of the United States of America  96: 846–851.  <ul class="find" data-citedArticleID="959384" data-doi="10.1073/pnas.96.3.846"><li><a href="http://dx.doi.org/10.1073/pnas.96.3.846" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mitochondrial+disease+in+superoxide+dismutase+2+mutant+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mitochondrial+disease+in+superoxide+dismutase+2+mutant+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0000536-Hinerfeld1" id="pone.0000536-Hinerfeld1"></a>Hinerfeld D, Traini MD, Weinberger RP, Cochran B, Doctrow SR, et al.  (2004) Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. Journal of Neurochemistry  88: 657–667.  <ul class="find" data-citedArticleID="959388" data-doi="10.1046/j.1471-4159.2003.02195.x"><li><a href="http://dx.doi.org/10.1046/j.1471-4159.2003.02195.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Endogenous+mitochondrial+oxidative+stress%3A+neurodegeneration%2C+proteomic+analysis%2C+specific+respiratory+chain+defects%2C+and+efficacious+antioxidant+therapy+in+superoxide+dismutase+2+null+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Endogenous+mitochondrial+oxidative+stress%3A+neurodegeneration%2C+proteomic+analysis%2C+specific+respiratory+chain+defects%2C+and+efficacious+antioxidant+therapy+in+superoxide+dismutase+2+null+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0000536-Ali1" id="pone.0000536-Ali1"></a>Ali SS, Hardt JI, Quick KL, Kim-Han JS, Erlanger BF, et al.  (2004) A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties. Free Radical Biology and Medicine  37: 1191–1202.  <ul class="find" data-citedArticleID="959428" data-doi="10.1016/j.freeradbiomed.2004.07.002"><li><a href="http://dx.doi.org/10.1016/j.freeradbiomed.2004.07.002" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+biologically+effective+fullerene+%28C60%29+derivative+with+superoxide+dismutase+mimetic+properties." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+biologically+effective+fullerene+%28C60%29+derivative+with+superoxide+dismutase+mimetic+properties.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0000536-Golden1" id="pone.0000536-Golden1"></a>Golden TR, Hubbard A, Morten KJ, Hinerfeld D, Melov S (2005) Pharmacogenomic profiling of an oxidative stress-mediated spongiform encephalopathy. Free Radical Biology and Medicine  39: 152–163.  <ul class="find" data-citedArticleID="959442" data-doi="10.1016/j.freeradbiomed.2005.03.002"><li><a href="http://dx.doi.org/10.1016/j.freeradbiomed.2005.03.002" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pharmacogenomic+profiling+of+an+oxidative+stress-mediated+spongiform+encephalopathy." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pharmacogenomic+profiling+of+an+oxidative+stress-mediated+spongiform+encephalopathy.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0000536-Barnham1" id="pone.0000536-Barnham1"></a>Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov  3: 205–214.  <ul class="find" data-citedArticleID="959464" data-doi="10.1038/nrd1330"><li><a href="http://dx.doi.org/10.1038/nrd1330" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Neurodegenerative+diseases+and+oxidative+stress." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Neurodegenerative+diseases+and+oxidative+stress.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0000536-Iqbal1" id="pone.0000536-Iqbal1"></a>Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, et al.  (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochimica et Biophysica Acta  1739: 198–210.  <ul class="find" data-citedArticleID="959400" data-doi="10.1016/j.bbadis.2004.09.008"><li><a href="http://dx.doi.org/10.1016/j.bbadis.2004.09.008" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Tau+pathology+in+Alzheimer+disease+and+other+tauopathies." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Tau+pathology+in+Alzheimer+disease+and+other+tauopathies.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0000536-Schonheit1" id="pone.0000536-Schonheit1"></a>Schonheit B, Zarski R, Ohm TG (2004) Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiology of Aging  25: 697–711.  <ul class="find" data-citedArticleID="959402" data-doi="10.1016/j.neurobiolaging.2003.09.009"><li><a href="http://dx.doi.org/10.1016/j.neurobiolaging.2003.09.009" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Spatial+and+temporal+relationships+between+plaques+and+tangles+in+Alzheimer-pathology." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Spatial+and+temporal+relationships+between+plaques+and+tangles+in+Alzheimer-pathology.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0000536-Huang2" id="pone.0000536-Huang2"></a>Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, et al.  (1999) The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry  38: 7609–7616.  <ul class="find" data-citedArticleID="959410" data-doi="10.1021/bi990438f"><li><a href="http://dx.doi.org/10.1021/bi990438f" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+A+beta+peptide+of+Alzheimer%27s+disease+directly+produces+hydrogen+peroxide+through+metal+ion+reduction." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+A+beta+peptide+of+Alzheimer%27s+disease+directly+produces+hydrogen+peroxide+through+metal+ion+reduction.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0000536-Opazo1" id="pone.0000536-Opazo1"></a>Opazo C, Huang X, Cherny RA, Moir RD, Roher AE, et al.  (2002) Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). J Biol Chem  277: 40302–40308.  <ul class="find" data-citedArticleID="959422" data-doi="10.1074/jbc.m206428200"><li><a href="http://dx.doi.org/10.1074/jbc.m206428200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Metalloenzyme-like+activity+of+Alzheimer%27s+disease+beta-amyloid.+Cu-dependent+catalytic+conversion+of+dopamine%2C+cholesterol%2C+and+biological+reducing+agents+to+neurotoxic+H%282%29O%282%29." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Metalloenzyme-like+activity+of+Alzheimer%27s+disease+beta-amyloid.+Cu-dependent+catalytic+conversion+of+dopamine%2C+cholesterol%2C+and+biological+reducing+agents+to+neurotoxic+H%282%29O%282%29.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0000536-Hsiao1" id="pone.0000536-Hsiao1"></a>Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, et al.  (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice [see comments]. Science  274: 99–102.  <ul class="find" data-citedArticleID="959380" data-doi="10.1126/science.274.5284.99"><li><a href="http://dx.doi.org/10.1126/science.274.5284.99" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Correlative+memory+deficits%2C+Abeta+elevation%2C+and+amyloid+plaques+in+transgenic+mice+%5Bsee+comments%5D." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Correlative+memory+deficits%2C+Abeta+elevation%2C+and+amyloid+plaques+in+transgenic+mice+%5Bsee+comments%5D.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0000536-Wirths1" id="pone.0000536-Wirths1"></a>Wirths O, Multhaup G, Czech C, Blanchard V, Moussaoui S, et al.  (2001) Intraneuronal Abeta accumulation precedes plaque formation in beta- amyloid precursor protein and presenilin-1 double-transgenic mice. Neuroscience Letters  306: 116–120.  <ul class="find" data-citedArticleID="959376" data-doi="10.1016/s0304-3940(01)01876-6"><li><a href="http://dx.doi.org/10.1016/s0304-3940(01)01876-6" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Intraneuronal+Abeta+accumulation+precedes+plaque+formation+in+beta-+amyloid+precursor+protein+and+presenilin-1+double-transgenic+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Intraneuronal+Abeta+accumulation+precedes+plaque+formation+in+beta-+amyloid+precursor+protein+and+presenilin-1+double-transgenic+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0000536-Richardson1" id="pone.0000536-Richardson1"></a>Richardson JA, Burns DK (2002) Mouse models of Alzheimer's disease: a quest for plaques and tangles. Ilar J  43: 89–99.  <ul class="find" data-citedArticleID="959374" data-doi="10.1093/ilar.43.2.89"><li><a href="http://dx.doi.org/10.1093/ilar.43.2.89" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mouse+models+of+Alzheimer%27s+disease%3A+a+quest+for+plaques+and+tangles." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mouse+models+of+Alzheimer%27s+disease%3A+a+quest+for+plaques+and+tangles.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0000536-Oddo1" id="pone.0000536-Oddo1"></a>Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, et al.  (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron  39: 409–421.  <ul class="find" data-citedArticleID="959456" data-doi="10.1016/s0896-6273(03)00434-3"><li><a href="http://dx.doi.org/10.1016/s0896-6273(03)00434-3" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Triple-transgenic+model+of+Alzheimer%27s+disease+with+plaques+and+tangles%3A+intracellular+Abeta+and+synaptic+dysfunction." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Triple-transgenic+model+of+Alzheimer%27s+disease+with+plaques+and+tangles%3A+intracellular+Abeta+and+synaptic+dysfunction.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0000536-Oddo2" id="pone.0000536-Oddo2"></a>Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiology of Aging  24: 1063–1070.  <ul class="find" data-citedArticleID="959408" data-doi="10.1016/j.neurobiolaging.2003.08.012"><li><a href="http://dx.doi.org/10.1016/j.neurobiolaging.2003.08.012" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Amyloid+deposition+precedes+tangle+formation+in+a+triple+transgenic+model+of+Alzheimer%27s+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Amyloid+deposition+precedes+tangle+formation+in+a+triple+transgenic+model+of+Alzheimer%27s+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0000536-Santacruz1" id="pone.0000536-Santacruz1"></a>Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, et al.  (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science  309: 476–481.  <ul class="find" data-citedArticleID="959404" data-doi="10.1126/science.1113694"><li><a href="http://dx.doi.org/10.1126/science.1113694" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Tau+suppression+in+a+neurodegenerative+mouse+model+improves+memory+function." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Tau+suppression+in+a+neurodegenerative+mouse+model+improves+memory+function.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0000536-Esposito1" id="pone.0000536-Esposito1"></a>Esposito L, Raber J, Kekonius L, Yan F, Yu GQ, et al.  (2006) Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci  26: 5167–5179.  <ul class="find" data-citedArticleID="959450" data-doi="10.1523/jneurosci.0482-06.2006"><li><a href="http://dx.doi.org/10.1523/jneurosci.0482-06.2006" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Reduction+in+mitochondrial+superoxide+dismutase+modulates+Alzheimer%27s+disease-like+pathology+and+accelerates+the+onset+of+behavioral+changes+in+human+amyloid+precursor+protein+transgenic+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Reduction+in+mitochondrial+superoxide+dismutase+modulates+Alzheimer%27s+disease-like+pathology+and+accelerates+the+onset+of+behavioral+changes+in+human+amyloid+precursor+protein+transgenic+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0000536-Li2" id="pone.0000536-Li2"></a>Li F, Calingasan NY, Yu F, Mauck WM, Toidze M, et al.  (2004) Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. Journal of Neurochemistry  89: 1308–1312.  <ul class="find" data-citedArticleID="959420" data-doi="10.1111/j.1471-4159.2004.02455.x"><li><a href="http://dx.doi.org/10.1111/j.1471-4159.2004.02455.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Increased+plaque+burden+in+brains+of+APP+mutant+MnSOD+heterozygous+knockout+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Increased+plaque+burden+in+brains+of+APP+mutant+MnSOD+heterozygous+knockout+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0000536-vanLeuven1" id="pone.0000536-vanLeuven1"></a>van Leuven F (2000) Single and multiple transgenic mice as models for Alzheimer's disease. Progress in Neurobiology  61: 305–312.  <ul class="find" data-citedArticleID="959358" data-doi="10.1016/s0301-0082(99)00055-6"><li><a href="http://dx.doi.org/10.1016/s0301-0082(99)00055-6" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Single+and+multiple+transgenic+mice+as+models+for+Alzheimer%27s+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Single+and+multiple+transgenic+mice+as+models+for+Alzheimer%27s+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0000536-Holcomb1" id="pone.0000536-Holcomb1"></a>Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, et al.  (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nature Medicine  4: 97–100.  <ul class="find" data-citedArticleID="959458" data-doi="10.1038/nm0198-097"><li><a href="http://dx.doi.org/10.1038/nm0198-097" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Accelerated+Alzheimer-type+phenotype+in+transgenic+mice+carrying+both+mutant+amyloid+precursor+protein+and+presenilin+1+transgenes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Accelerated+Alzheimer-type+phenotype+in+transgenic+mice+carrying+both+mutant+amyloid+precursor+protein+and+presenilin+1+transgenes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0000536-Callahan1" id="pone.0000536-Callahan1"></a>Callahan MJ, Lipinski WJ, Bian F, Durham RA, Pack A, et al.  (2001) Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. American Journal of Pathology  158: 1173–1177.  <ul class="find" data-citedArticleID="959444" data-doi="10.1016/s0002-9440(10)64064-3"><li><a href="http://dx.doi.org/10.1016/s0002-9440(10)64064-3" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Augmented+senile+plaque+load+in+aged+female+beta-amyloid+precursor+protein-transgenic+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Augmented+senile+plaque+load+in+aged+female+beta-amyloid+precursor+protein-transgenic+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0000536-Kobayashi1" id="pone.0000536-Kobayashi1"></a>Kobayashi K, Miyazu K, Fukutani Y, Nakamura I, Yamaguchi N (1992) Gallyas-Schiff stain for senile plaques. Biotechnic and Histochemistry  67: 256–260.  <ul class="find" data-citedArticleID="959424" data-doi="10.3109/10520299209110033"><li><a href="http://dx.doi.org/10.3109/10520299209110033" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Gallyas-Schiff+stain+for+senile+plaques." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Gallyas-Schiff+stain+for+senile+plaques.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0000536-Augustinack1" id="pone.0000536-Augustinack1"></a>Augustinack JC, Schneider A, Mandelkow EM, Hyman BT (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathologica  103: 26–35.  <ul class="find" data-citedArticleID="959398" data-doi="10.1007/s004010100423"><li><a href="http://dx.doi.org/10.1007/s004010100423" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Specific+tau+phosphorylation+sites+correlate+with+severity+of+neuronal+cytopathology+in+Alzheimer%27s+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Specific+tau+phosphorylation+sites+correlate+with+severity+of+neuronal+cytopathology+in+Alzheimer%27s+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0000536-White1" id="pone.0000536-White1"></a>White H (1980) A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica  48: 817–830.  <ul class="find" data-citedArticleID="959454" data-doi="10.2307/1912934"><li><a href="http://dx.doi.org/10.2307/1912934" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+heteroskedasticity-consistent+covariance+matrix+estimator+and+a+direct+test+for+heteroskedasticity." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+heteroskedasticity-consistent+covariance+matrix+estimator+and+a+direct+test+for+heteroskedasticity.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0000536-Perkins1" id="pone.0000536-Perkins1"></a>Perkins DN, Pappin DJ, Creasy DM, Cottrell JS (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis  20: 3551–3567.  <ul class="find" data-citedArticleID="959366" data-doi="10.1002/(sici)1522-2683(19991201)20:18<3551::aid-elps3551&gt;3.0.co;2-2"><li><a href="http://dx.doi.org/10.1002/(sici)1522-2683(19991201)20:18<3551::aid-elps3551&gt;3.0.co;2-2" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Probability-based+protein+identification+by+searching+sequence+databases+using+mass+spectrometry+data." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Probability-based+protein+identification+by+searching+sequence+databases+using+mass+spectrometry+data.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0000536-Maynard1" id="pone.0000536-Maynard1"></a>Maynard CJ, Cappai R, Volitakis I, Cherny RA, Masters CL, et al.  (2006) Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology. J Inorg Biochem  100: 952–962.  <ul class="find" data-citedArticleID="959414" data-doi="10.1016/j.jinorgbio.2006.02.010"><li><a href="http://dx.doi.org/10.1016/j.jinorgbio.2006.02.010" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Gender+and+genetic+background+effects+on+brain+metal+levels+in+APP+transgenic+and+normal+mice%3A+implications+for+Alzheimer+beta-amyloid+pathology." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Gender+and+genetic+background+effects+on+brain+metal+levels+in+APP+transgenic+and+normal+mice%3A+implications+for+Alzheimer+beta-amyloid+pathology.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0000536-Bancroft1" id="pone.0000536-Bancroft1"></a>Bancroft JD, Stevens A (1996) Theory and Practice of Histological Techniques. New York: Churchill Livingtone.   <ul class="find-nolinks"></ul></li><li><span class="label">37.
              </span><a name="pone.0000536-Dewachter1" id="pone.0000536-Dewachter1"></a>Dewachter I, van Dorpe J, Spittaels K, Tesseur I, Van Den Haute C, et al.  (2000) Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice. Experimental Gerontology  35: 831–841.  <ul class="find" data-citedArticleID="959360" data-doi="10.1016/s0531-5565(00)00149-2"><li><a href="http://dx.doi.org/10.1016/s0531-5565(00)00149-2" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Modeling+Alzheimer%27s+disease+in+transgenic+mice%3A+effect+of+age+and+of+presenilin1+on+amyloid+biochemistry+and+pathology+in+APP%2FLondon+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Modeling+Alzheimer%27s+disease+in+transgenic+mice%3A+effect+of+age+and+of+presenilin1+on+amyloid+biochemistry+and+pathology+in+APP%2FLondon+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">38.
              </span><a name="pone.0000536-Bellingham1" id="pone.0000536-Bellingham1"></a>Bellingham SA, Ciccotosto GD, Needham BE, Fodero LR, White AR, et al.  (2004) Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts. J Neurochem  91: 423–428.  <ul class="find" data-citedArticleID="959406" data-doi="10.1111/j.1471-4159.2004.02731.x"><li><a href="http://dx.doi.org/10.1111/j.1471-4159.2004.02731.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Gene+knockout+of+amyloid+precursor+protein+and+amyloid+precursor-like+protein-2+increases+cellular+copper+levels+in+primary+mouse+cortical+neurons+and+embryonic+fibroblasts." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Gene+knockout+of+amyloid+precursor+protein+and+amyloid+precursor-like+protein-2+increases+cellular+copper+levels+in+primary+mouse+cortical+neurons+and+embryonic+fibroblasts.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">39.
              </span><a name="pone.0000536-Maynard2" id="pone.0000536-Maynard2"></a>Maynard CJ, Cappai R, Volitakis I, Cherny RA, White AR, et al.  (2002) Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J Biol Chem  277: 44670–44676.  <ul class="find" data-citedArticleID="959434" data-doi="10.1074/jbc.m204379200"><li><a href="http://dx.doi.org/10.1074/jbc.m204379200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Overexpression+of+Alzheimer%27s+disease+amyloid-beta+opposes+the+age-dependent+elevations+of+brain+copper+and+iron." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Overexpression+of+Alzheimer%27s+disease+amyloid-beta+opposes+the+age-dependent+elevations+of+brain+copper+and+iron.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">40.
              </span><a name="pone.0000536-Bayer1" id="pone.0000536-Bayer1"></a>Bayer TA, Schafer S, Simons A, Kemmling A, Kamer T, et al.  (2003) Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc Natl Acad Sci U S A  100: 14187–14192.  <ul class="find" data-citedArticleID="959396" data-doi="10.1073/pnas.2332818100"><li><a href="http://dx.doi.org/10.1073/pnas.2332818100" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Dietary+Cu+stabilizes+brain+superoxide+dismutase+1+activity+and+reduces+amyloid+Abeta+production+in+APP23+transgenic+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Dietary+Cu+stabilizes+brain+superoxide+dismutase+1+activity+and+reduces+amyloid+Abeta+production+in+APP23+transgenic+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">41.
              </span><a name="pone.0000536-Phinney1" id="pone.0000536-Phinney1"></a>Phinney AL, Drisaldi B, Schmidt SD, Lugowski S, Coronado V, et al.  (2003) In vivo reduction of amyloid-beta by a mutant copper transporter. Proc Natl Acad Sci U S A  100: 14193–14198.  <ul class="find" data-citedArticleID="959448" data-doi="10.1073/pnas.2332851100"><li><a href="http://dx.doi.org/10.1073/pnas.2332851100" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=In+vivo+reduction+of+amyloid-beta+by+a+mutant+copper+transporter." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22In+vivo+reduction+of+amyloid-beta+by+a+mutant+copper+transporter.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">42.
              </span><a name="pone.0000536-Bush1" id="pone.0000536-Bush1"></a>Bush AI, Pettingell WH, Multhaup G, d Paradis M, Vonsattel JP, et al.  (1994) Rapid induction of Alzheimer A beta amyloid formation by zinc. Science  265: 1464–1467.  <ul class="find" data-citedArticleID="959394" data-doi="10.1126/science.8073293"><li><a href="http://dx.doi.org/10.1126/science.8073293" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Rapid+induction+of+Alzheimer+A+beta+amyloid+formation+by+zinc." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Rapid+induction+of+Alzheimer+A+beta+amyloid+formation+by+zinc.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">43.
              </span><a name="pone.0000536-Galas1" id="pone.0000536-Galas1"></a>Galas MC, Dourlen P, Begard S, Ando K, Blum D, et al.  (2006) The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease. J Biol Chem  281: 19296–19304.  <ul class="find" data-citedArticleID="959432" data-doi="10.1074/jbc.m601849200"><li><a href="http://dx.doi.org/10.1074/jbc.m601849200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+peptidylprolyl+cis%2Ftrans-isomerase+Pin1+modulates+stress-induced+dephosphorylation+of+Tau+in+neurons.+Implication+in+a+pathological+mechanism+related+to+Alzheimer+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+peptidylprolyl+cis%2Ftrans-isomerase+Pin1+modulates+stress-induced+dephosphorylation+of+Tau+in+neurons.+Implication+in+a+pathological+mechanism+related+to+Alzheimer+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">44.
              </span><a name="pone.0000536-Blass1" id="pone.0000536-Blass1"></a>Blass JP (2001) Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia? Journal of Neuroscience Research  66: 851–856.  <ul class="find" data-citedArticleID="959412" data-doi="10.1002/jnr.10087"><li><a href="http://dx.doi.org/10.1002/jnr.10087" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Brain+metabolism+and+brain+disease%3A+is+metabolic+deficiency+the+proximate+cause+of+Alzheimer+dementia%3F" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Brain+metabolism+and+brain+disease%3A+is+metabolic+deficiency+the+proximate+cause+of+Alzheimer+dementia%3F%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">45.
              </span><a name="pone.0000536-Smith1" id="pone.0000536-Smith1"></a>Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PL, et al.  (1998) Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. Journal of Neurochemistry  70: 2212–2215.  <ul class="find" data-citedArticleID="959436" data-doi="10.1046/j.1471-4159.1998.70052212.x"><li><a href="http://dx.doi.org/10.1046/j.1471-4159.1998.70052212.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Amyloid-beta+deposition+in+Alzheimer+transgenic+mice+is+associated+with+oxidative+stress." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Amyloid-beta+deposition+in+Alzheimer+transgenic+mice+is+associated+with+oxidative+stress.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">46.
              </span><a name="pone.0000536-Smith2" id="pone.0000536-Smith2"></a>Smith MA, Hirai K, Nunomura A, Perry G (1999) Mitochondrial Abnormalities: A Primary Basis for Oxidative Damage in Alzheimer's Disease. Drug Develop Res  46: 26–33.  <ul class="find" data-citedArticleID="959462" data-doi="10.1002/(sici)1098-2299(199901)46:1<26::aid-ddr5&gt;3.0.co;2-8"><li><a href="http://dx.doi.org/10.1002/(sici)1098-2299(199901)46:1<26::aid-ddr5&gt;3.0.co;2-8" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mitochondrial+Abnormalities%3A+A+Primary+Basis+for+Oxidative+Damage+in+Alzheimer%27s+Disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mitochondrial+Abnormalities%3A+A+Primary+Basis+for+Oxidative+Damage+in+Alzheimer%27s+Disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">47.
              </span><a name="pone.0000536-Lustbader1" id="pone.0000536-Lustbader1"></a>Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, et al.  (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science  304: 448–452.  <ul class="find" data-citedArticleID="959430" data-doi="10.1126/science.1091230"><li><a href="http://dx.doi.org/10.1126/science.1091230" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=ABAD+directly+links+Abeta+to+mitochondrial+toxicity+in+Alzheimer%27s+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22ABAD+directly+links+Abeta+to+mitochondrial+toxicity+in+Alzheimer%27s+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">48.
              </span><a name="pone.0000536-Takuma1" id="pone.0000536-Takuma1"></a>Takuma K, Yao J, Huang J, Xu H, Chen X, et al.  (2005) ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. Faseb J  19: 597–598.  <ul class="find" data-citedArticleID="959460" data-doi="10.1096/fj.04-2582fje"><li><a href="http://dx.doi.org/10.1096/fj.04-2582fje" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=ABAD+enhances+Abeta-induced+cell+stress+via+mitochondrial+dysfunction." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22ABAD+enhances+Abeta-induced+cell+stress+via+mitochondrial+dysfunction.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">49.
              </span><a name="pone.0000536-Crouch1" id="pone.0000536-Crouch1"></a>Crouch PJ, Barnham KJ, Bush AI, White AR (2006) Therapeutic treatments for Alzheimer's disease based on metal bioavailability. Drug News Perspect  19: 469–474.  <ul class="find" data-citedArticleID="959370" data-doi="10.1358/dnp.2006.19.8.1021492"><li><a href="http://dx.doi.org/10.1358/dnp.2006.19.8.1021492" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Therapeutic+treatments+for+Alzheimer%27s+disease+based+on+metal+bioavailability." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Therapeutic+treatments+for+Alzheimer%27s+disease+based+on+metal+bioavailability.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">50.
              </span><a name="pone.0000536-Marcus1" id="pone.0000536-Marcus1"></a>Marcus DL, Strafaci JA, Freedman ML (2006) Differential neuronal expression of manganese superoxide dismutase in Alzheimer's disease. Med Sci Monit  12: BR8–14.  <ul class="find" data-citedArticleID="959364"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Differential+neuronal+expression+of+manganese+superoxide+dismutase+in+Alzheimer%27s+disease.&amp;auth=&amp;atitle=Differential+neuronal+expression+of+manganese+superoxide+dismutase+in+Alzheimer%27s+disease." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Differential+neuronal+expression+of+manganese+superoxide+dismutase+in+Alzheimer%27s+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Differential+neuronal+expression+of+manganese+superoxide+dismutase+in+Alzheimer%27s+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">51.
              </span><a name="pone.0000536-VanRemmen2" id="pone.0000536-VanRemmen2"></a>Van Remmen H, Salvador C, Yang H, Huang TT, Epstein CJ, et al.  (1999) Characterization of the antioxidant status of the heterozygous manganese superoxide dismutase knockout mouse. Archives of Biochemistry and Biophysics  363: 91–97.  <ul class="find" data-citedArticleID="959466" data-doi="10.1006/abbi.1998.1060"><li><a href="http://dx.doi.org/10.1006/abbi.1998.1060" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Characterization+of+the+antioxidant+status+of+the+heterozygous+manganese+superoxide+dismutase+knockout+mouse." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Characterization+of+the+antioxidant+status+of+the+heterozygous+manganese+superoxide+dismutase+knockout+mouse.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">52.
              </span><a name="pone.0000536-VanRemmen3" id="pone.0000536-VanRemmen3"></a>Van Remmen H, Williams MD, Guo Z, Estlack L, Yang H, et al.  (2001) Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis. Am J Physiol Heart Circ Physiol  281: H1422–1432.  <ul class="find" data-citedArticleID="959372"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Knockout+mice+heterozygous+for+Sod2+show+alterations+in+cardiac+mitochondrial+function+and+apoptosis.&amp;auth=&amp;atitle=Knockout+mice+heterozygous+for+Sod2+show+alterations+in+cardiac+mitochondrial+function+and+apoptosis." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Knockout+mice+heterozygous+for+Sod2+show+alterations+in+cardiac+mitochondrial+function+and+apoptosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Knockout+mice+heterozygous+for+Sod2+show+alterations+in+cardiac+mitochondrial+function+and+apoptosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">53.
              </span><a name="pone.0000536-DiasSantagata1" id="pone.0000536-DiasSantagata1"></a>Dias-Santagata D, Fulga TA, Duttaroy A, Feany MB (2007) Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J Clin Invest  117: 236–245.  <ul class="find" data-citedArticleID="959386" data-doi="10.1172/jci28769"><li><a href="http://dx.doi.org/10.1172/jci28769" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Oxidative+stress+mediates+tau-induced+neurodegeneration+in+Drosophila." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Oxidative+stress+mediates+tau-induced+neurodegeneration+in+Drosophila.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">54.
              </span><a name="pone.0000536-Li3" id="pone.0000536-Li3"></a>Li B, Chohan MO, Grundke-Iqbal I, Iqbal K (2007) Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau. Acta Neuropathol (Berl)  113: 501–511.  <ul class="find" data-citedArticleID="959418" data-doi="10.1007/s00401-007-0207-8"><li><a href="http://dx.doi.org/10.1007/s00401-007-0207-8" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Disruption+of+microtubule+network+by+Alzheimer+abnormally+hyperphosphorylated+tau." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Disruption+of+microtubule+network+by+Alzheimer+abnormally+hyperphosphorylated+tau.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">55.
              </span><a name="pone.0000536-Cherny1" id="pone.0000536-Cherny1"></a>Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, et al.  (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron  30: 665–676.  <ul class="find" data-citedArticleID="959446" data-doi="10.1016/s0896-6273(01)00317-8"><li><a href="http://dx.doi.org/10.1016/s0896-6273(01)00317-8" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Treatment+with+a+copper-zinc+chelator+markedly+and+rapidly+inhibits+beta-amyloid+accumulation+in+Alzheimer%27s+disease+transgenic+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Treatment+with+a+copper-zinc+chelator+markedly+and+rapidly+inhibits+beta-amyloid+accumulation+in+Alzheimer%27s+disease+transgenic+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.XML" value="129086"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.PDF" value="483766"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g001.PNG_L" value="500090"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g001.PNG_M" value="115635"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g001.PNG_S" value="16190"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g001.TIF" value="897708"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g001.PNG_I" value="26014"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.e001.PNG" value="25675"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.e001.TIF" value="44172"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.t001.PNG_L" value="212946"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.t001.PNG_M" value="283406"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.t001.PNG_S" value="19584"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.t001.TIF" value="830140"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.t001.PNG_I" value="40783"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g002.PNG_L" value="92899"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g002.PNG_M" value="56864"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g002.PNG_S" value="8317"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g002.TIF" value="158434"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g002.PNG_I" value="6995"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g003.PNG_L" value="9049662"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g003.PNG_M" value="1282277"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g003.PNG_S" value="47536"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g003.TIF" value="11148736"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g003.PNG_I" value="388341"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g004.PNG_L" value="359983"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g004.PNG_M" value="47203"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g004.PNG_S" value="15210"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g004.TIF" value="655424"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g004.PNG_I" value="33891"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g005.PNG_L" value="82597"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g005.PNG_M" value="90290"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g005.PNG_S" value="10299"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g005.TIF" value="147506"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g005.PNG_I" value="10049"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g006.PNG_L" value="406868"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g006.PNG_M" value="97114"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g006.PNG_S" value="13382"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g006.TIF" value="829424"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g006.PNG_I" value="20242"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g007.PNG_L" value="212208"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g007.PNG_M" value="219001"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g007.PNG_S" value="19853"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g007.TIF" value="320794"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g007.PNG_I" value="33998"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g008.PNG_L" value="23787"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g008.PNG_M" value="26908"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g008.PNG_S" value="3016"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g008.TIF" value="37640"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000536.g008.PNG_I" value="4780"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000536&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000536" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000536&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0000536&volume=&issue=&title=Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau&author_name=Simon%20Melov%2C%20Paul%20A.%20Adlard%2C%20Karl%20Morten%2C%20Felicity%20Johnson%2C%20Tamara%20R.%20Golden%2C%20Doug%20Hinerfeld%2C%20Birgit%20Schilling%2C%20Christine%20Mavros%2C%20Colin%20L.%20Masters%2C%20Irene%20Volitakis%2C%20Qiao-Xin%20Li%2C%20Katrina%20Laughton%2C%20Alan%20Hubbard%2C%20Robert%20A.%20Cherny%2C%20Brad%20Gibson%2C%20Ashley%20I.%20Bush&start_page=1&end_page=12" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000536" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000536" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0000536" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000536&amp;t=Mitochondrial%20Oxidative%20Stress%20Causes%20Hyperphosphorylation%20of%20Tau" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000536&title=Mitochondrial%20Oxidative%20Stress%20Causes%20Hyperphosphorylation%20of%20Tau&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000536&amp;title=Mitochondrial%20Oxidative%20Stress%20Causes%20Hyperphosphorylation%20of%20Tau" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000536" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0000536&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0000536';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Mitochondrial%20Oxidative%20Stress%20Causes%20Hyperphosphorylation%20of%20Tau http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000536" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0000536" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">











          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Alzheimer+disease%22" title="Search for articles in the subject area:'Alzheimer disease'"><div class="flagText">Alzheimer disease</div></a>
              <div data-categoryid="31879" data-articleid="23910"
                   data-categoryname="Alzheimer disease"
                   class="flagImage" title="Flag 'Alzheimer disease' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Antioxidants%22" title="Search for articles in the subject area:'Antioxidants'"><div class="flagText">Antioxidants</div></a>
              <div data-categoryid="21585" data-articleid="23910"
                   data-categoryname="Antioxidants"
                   class="flagImage" title="Flag 'Antioxidants' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Manganese%22" title="Search for articles in the subject area:'Manganese'"><div class="flagText">Manganese</div></a>
              <div data-categoryid="22337" data-articleid="23910"
                   data-categoryname="Manganese"
                   class="flagImage" title="Flag 'Manganese' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Mitochondria%22" title="Search for articles in the subject area:'Mitochondria'"><div class="flagText">Mitochondria</div></a>
              <div data-categoryid="32453" data-articleid="23910"
                   data-categoryname="Mitochondria"
                   class="flagImage" title="Flag 'Mitochondria' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Mouse+models%22" title="Search for articles in the subject area:'Mouse models'"><div class="flagText">Mouse models</div></a>
              <div data-categoryid="32069" data-articleid="23910"
                   data-categoryname="Mouse models"
                   class="flagImage" title="Flag 'Mouse models' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Oxidative+stress%22" title="Search for articles in the subject area:'Oxidative stress'"><div class="flagText">Oxidative stress</div></a>
              <div data-categoryid="20651" data-articleid="23910"
                   data-categoryname="Oxidative stress"
                   class="flagImage" title="Flag 'Oxidative stress' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Peptides%22" title="Search for articles in the subject area:'Peptides'"><div class="flagText">Peptides</div></a>
              <div data-categoryid="17847" data-articleid="23910"
                   data-categoryname="Peptides"
                   class="flagImage" title="Flag 'Peptides' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Phosphorylation%22" title="Search for articles in the subject area:'Phosphorylation'"><div class="flagText">Phosphorylation</div></a>
              <div data-categoryid="42723" data-articleid="23910"
                   data-categoryname="Phosphorylation"
                   class="flagImage" title="Flag 'Phosphorylation' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=386'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=8614'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=3732&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
